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Abstract 
The present work introduces a detailed study related to the synthesis of novel silicon oxycarbide based 
glasses and glass-ceramics as well as their in vitro bioactivity, i.e., their ability to induce surface miner-
alization of hydroxyapatite upon exposure to simulated body fluid (SBF). The focus of the work was to 
rationalize the correlations between the structural features of the prepared silicon oxycarbide based 
materials and their bioactivity. Thus, the effect of the glass network architecture, of secondary phases 
as well as of the specific surface area and porosity on the bioactivity of silicon oxycarbide was investi-
gated. This was achieved upon modification of the silicon oxycarbide glass network with additional ele-
ments, i.e., B, Ca, Sr, which were shown to affect both the glass network architecture and the phase 
composition of the prepared silicon oxycarbides. Moreover, the specific surface area of the prepared 
materials was modulated upon adjusting their synthetic procedure, as shown exemplarily in the present 
work for Ca-modified silicon oxycarbide glasses. 
The incorporation of additional B, Ca and/or Sr elements into silicon oxycarbide modified its microstruc-
ture in three different ways: (i) by forming minor soluble secondary calcium silicate and/or strontium 
silicate phases as for Ca and Sr modification, (ii) by introducing Q3 units (silicon tetrahedra with one 
non-bridging-oxygen) into silicon oxycarbide amorphous network as for Ca modification and (iii) by re-
ducing network carbon content as for B modification. The dissolution of crystalline silicate phases during 
bioactivity assessment of prepared silicon oxycarbide materials in SBF solution resulted in increased Si 
release, which was beneficial for apatite formation. On the other hand, both the formation of Q3 units 
and the decrease of carbon content in the glassy network decreased its network connectivity (NC). The 
less connected network architecture was responsible for the improved bioactivity of the investigated 
silicon oxycarbide materials. Furthermore, the slight network depolymerization effect upon Q3 formation 
was found to have a higher influence on the silicon oxycarbide bioactivity than network carbon content. 
Thus, slight network depolymerization in silicon oxycarbide based glasses is sufficient to achieve high 
bioactivity. 
The specific surface area and the porosity of silicon oxycarbide were modulated in a case study on sol-
gel based Ca-modified silicon oxycarbide glasses. Thereafter, the introduction of Ca into the oxycarbide 
glass was shown to have significant effects on the structural features of the prepared xerogels as well 
as the resulting Ca-containing silicon oxycarbide glasses. Moderate content of Ca modifier was shown 
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to generate mesoporosity in the xerogel and stabilize it against collapse; while higher content resulted 
in a significantly reduced surface area and porosity in the xerogel. Moreover, two main effects were 
observed in the resulting oxycarbide glasses: (i) moderate Ca content led to high surface area and 
amorphous glasses and (ii) high Ca content induced the formation of calcium silicate secondary phase. 
It was shown in this case study that high specific surface area, which was provided by relatively large 
fractions of mesoporosity, is highly beneficial for achieving high bioactivity. 
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Zusammenfassung 
In der vorliegenden Arbeit wird eine detaillierte Studie vorgestellt, die sich mit der Synthese neuartiger 
Siliziumoxycarbid-basierter Gläser und Glaskeramiken sowie mit ihrer in vitro Bioaktivität befasst, d. h. 
mit ihrer Fähigkeit, eine Oberflächenmineralisierung von Hydroxylapatit bei ihrer Aussetzung in simu-
lierter Körperflüssigkeit (SBF) zu induzieren. Der Schwerpunkt der Arbeit lag daran, die Korrelationen 
zwischen den Strukturmerkmalen der hergestellten Siliziumoxycarbid-basierten Materialien und ihrer 
Bioaktivität zu rationalisieren. Dementsprechend wurde der Einfluss der Glasnetzwerkarchitektur, der 
Sekundärphasen sowie der spezifischen Oberfläche und Porosität auf die Bioaktivität von Silizi-
umoxycarbid untersucht. Dies wurde erreicht durch Modifikation des Siliziumoxycarbid-Glasnetzwerks 
mit zusätzlichen Elementen, d. h. B, Ca, Sr. Es wurde gezeigt, dass sie sowohl die Glasnetzwerkarchi-
tektur als auch die Phasenzusammensetzung der hergestellten Siliziumoxycarbide beeinflussten. Dar-
über hinaus wurde die spezifische Oberfläche der hergestellten Materialien durch das Einstellen ihres 
Syntheseverfahrens moduliert, wie dies beispielhaft in der vorliegenden Arbeit für Ca-modifizierte Silizi-
umoxycarbid-Gläser gezeigt wurde. 
Der Einbau zusätzlicher B, Ca und / oder Sr Elemente in Siliziumoxycarbid modifizierte seine Mikro-
struktur auf drei verschiedene Arten: (i) durch Bildung von geringfügigen löslichen sekundären Kalzium-
silikat- und / oder Strontiumsilikat-Phasen wie bei der Ca- und Sr-Modifikation, (ii) durch Einführen von 
Q3-Einheiten (Siliziumtetraeder mit einem nicht-brückenden-Sauerstoff) in das amorphe Siliziumoxycar-
bid-Netzwerk wie bei der Ca-Modifikation und (iii) durch Verringern des Netzwerkkohlenstoffgehalts wie 
bei der B-Modifikation. Die Auflösung kristalliner Silikat-Phasen während der Bioaktivitätsauswertung 
von hergestellten Siliziumoxycarbid-Materialien in SBF-Lösung führte zu einer erhöhten Si-Freisetzung, 
die für die Apatit-Bildung von Vorteil war. Andererseits verringerten sowohl die Bildung von Q3-Einheiten 
als auch die Abnahme des Kohlenstoffgehalts im glasartigen Netzwerk die Netzwerkkonnektivität (NC). 
Die weniger vernetzte Netzwerkarchitektur war für die verbesserte Bioaktivität der untersuchten Silizi-
umoxycarbid-Materialien verantwortlich. Darüber hinaus wurde festgestellt, dass die leichte Netzwerk-
Depolymerisation bei der Q3-Bildung einen höheren Einfluss auf die Bioaktivität von Siliziumoxycarbid 
als der Netzwerkkohlenstoffgehalt hatte. Eine leichte Depolymerisation des Glasnetzwerks von Silizi-
umoxycarbid ist daher ausreichend, um eine hohe Bioaktivität zu erzielen. 
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Die spezifische Oberfläche und die Porosität von Siliziumoxycarbid wurden in einer Fallstudie an Sol-
Gel abgeleiteten Ca-modifizierten Siliziumoxycarbid-Gläsern moduliert. Demnach wurde es gezeigt, 
dass die Einführung von Ca in das Oxycarbid-Glas bedeutende Auswirkungen auf die Strukturmerkmale 
der hergestellten Xerogele sowie der sich daraus ergebenen Ca-haltigen Siliziumoxycarbid-Gläser hatte. 
Es wurde gezeigt, dass ein mäßiger Gehalt an Ca-Modifikator Mesoporosität im Xerogel erzeugte und 
sie gegen Kollaps stabilisierte; während ein höherer Gehalt zu deutlich verringerter Oberfläche und Po-
rosität im Xerogel führte. Darüber hinaus wurden bei den resultierenden Oxycarbid-Gläsern zwei Haupt-
effekte beobachtet: (i) ein mäßiger Ca-Gehalt führte zu einer hohen Oberfläche und amorphen Gläsern 
und (ii) ein hoher Ca-Gehalt induzierte die Bildung der Kalziumsilikat-Sekundärphase. In dieser Fallstu-
die wurde gezeigt, dass eine hohe spezifische Oberfläche, die durch relativ große Anteile an Mesopo-
rosität bereitgestellt wurde, für eine verbesserte Bioaktivität von großem Vorteil ist. 
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1. Scope and Motivation 
The clinical treatment of critical size bone defects requires the usage of bioactive materials to trigger or 
accelerate natural bone healing process [1]. Bioactive glasses have been important bone grafting ma-
terials since the discovery of Bioglass® 45S5 (45 wt.% SiO2, 24.5 wt.% CaO, 24.5 wt.% Na2O and 6.0 
wt.% P2O5) by LL Hench [2]. The ability of bioactive glasses to induce hydroxyapatite (bone mineral) 
formation during contact with physiological fluids provides a high bone-bonding ability [3]. Furthermore, 
leaching products from bioactive glasses have effects on promoting osteogenesis and angiogenesis, 
enhancing new bone formation [4]. The high bioactivity of bioactive glasses is correlated to their weak 
network structure, allowing fast glass dissolution in physiological fluids. The weakening of glass network 
is realized by incorporating high content of network modifiers, i.e., alkali or alkaline earth metal ions, in 
glass compositions. 
However, some drawbacks related to high alkali content in bioactive glasses have been reported. On 
one hand, the fast dissolution of alkali ions leads to high pH environment, which may be cytotoxic [5]. 
On the other hand, weak network structure leads to low mechanical strength and a high crystallization 
tendency of bioactive glasses. The fabrication of 3D scaffold from bioactive glasses is thus difficult, since 
the partial glass crystallization at processing temperature can lead to mechanical instability [6, 7]. More-
over, the degradation of bioactive glasses is too fast, and not able to match slower new bone formation 
[8]. 
Correspondingly, significant work has been done, in order to solve the issues of alkali-containing bioac-
tive glasses. Alkali-free bioactive glasses have been developed by replacing alkali metals with alkaline 
earth metals [9, 10]. Bioactive glasses with relatively large processing window has been achieved by 
optimizing glass composition [11, 12]. Bioactive ceramics, such as calcium silicate, tricalcium phosphate 
and synthetic hydroxyapatite, have shown high bone-bonding ability and low ceramic degradation in 
human body fluid [13, 14]. Furthermore, composite materials, such as glass-ceramic or glass-polymer 
composites, have shown mechanical properties that can fulfill clinical requirements [3, 12, 15]. In gen-
eral, these research works are based on the optimization of original Bioglass® 45S5 composition or on 
the modification of well-known bioceramics. 
In the present work, a new generation of alkali-free bioactive materials based on amorphous silicon 
oxycarbide will be investigated. Clinical application requires high biocompatibility, high mechanical 
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strength, high processability and tunable bioactivity of bioactive materials. Silicon oxycarbide is a prom-
ising candidate to fulfill these requirements: (i) the mix-bonded structure of Si-O and Si-C in silicon 
oxycarbide provides higher intrinsic mechanical strength than that of vitreous silica; (ii) the synthesis of 
silicon oxycarbide via so-called polymer derived ceramic method makes it possible to apply polymer 
forming techniques for fabricating silicon oxycarbide implants; (iii) the carbon incorporation in silicon 
oxycarbide creates unique oxycarbide matrix / ”free carbon” nano-domain structure, which shows high 
temperature crystallization resistance that is beneficial for the thermal processing of the materials [16]; 
(iv) the modification of silicon oxycarbide with metal elements has been investigated extensively [17], 
and the incorporation of therapeutic metal ions in silicon oxycarbide can be easily realized. 
Until now, the high biocompatibility, i.e., non-cytotoxicity, of silicon oxycarbide has been confirmed in 
several studies [18, 19]. Preliminary research work has proven the ability of silicon oxycarbide to show 
bioactivity, i.e., apatite forming ability, in simulated body fluid [20, 21]. However, a systematic investiga-
tion on the structure-property correlation for bioactive silicon oxycarbide materials still needs to be done. 
For this purpose, two approaches have been applied in the present study. Firstly, the network architec-
ture and phase composition of silicon oxycarbide will be modified by incorporating alkaline earth metals 
(Ca and Sr) and an additional network former (B). Secondly, the porosity of silicon oxycarbide will be 
varied via sol-gel process. The correlation between these structural features and observed bioactivity 
upon SBF assessment will be discussed. 
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2. Fundamentals and State of the Art 
2.1. Silicon oxycarbide 
The use of silicon oxycarbide as a material name can be traced back to the begin of 20th century, where 
silicon oxycarbide was referred to a carbon-silica mixture for high-temperature insulating applications 
[22]. Since the 1990s, the term of silicon oxycarbide has been restricted to materials, which contains not 
only carbon in elementary form (sp2 carbon), but also network carbon (sp3 carbon) [23]. Thus, the coex-
isting of Si-C and Si-O covalent bonds is characteristic for silicon oxycarbide. 
Due to the high temperature carbothermal reaction between silica and carbon and the extremely low 
solubility of carbon in silicon oxide, silicon oxycarbide is difficult to be synthesized via conventional solid 
state reaction from inorganic sources [24, 25]. The possibility to incorporate carbon into silica network, 
as in the case of silicon oxycarbide, has been essentially limited to several methods, namely chemical 
vapor deposition (CVD), radio frequency (RF) magnetron sputtering, polymer derived ceramic (PDC). In 
CVD method, organic small-molecular Si species, such as siloxanes and carbosilanes, are deposited 
on substrates to form silicon oxycarbide thin films under energy input (i.e., laser, heat etc.) [26, 27]. In 
typical RF magnetron sputtering, SiC ceramic target is sputtered in Ar/O2 gas flow to synthesize amor-
phous silicon oxycarbide thin films or coatings [28, 29]. In PDC method, organic Si-containing monomers 
or oligomers, such as siloxanes and silsesquioxane, are crosslinked to polymer chains or networks, 
which then undergo thermal decomposition under non-oxidative gas atmosphere (i.e., Ar or N2). The 
lack of oxidation reaction during the thermolysis preserves the Si-C/Si-O bonds, that already exist in 
polymer structure, in obtained silicon oxycarbide [30, 31]. Compared to the high complexity and cost of 
CVD and RF magnetron sputtering processes, PDC method prevails thanks to its similarity to a conven-
tional ceramic calcination / sintering process. Besides, the possibility to apply polymer forming tech-
niques to polymer precursors in PDC method allows to achieve different material forms for silicon ox-
ycarbide, ranging from coatings, monoliths to porous structures [32]. 
Tetravalent sp3 hybridized network carbon in silicon oxycarbide leads to more connected network struc-
ture, which is shown to improve its mechanical properties compared to vitreous silica [33, 34]. Silicon 
oxycarbide is also a high temperature material and has outstanding oxidation resistance [35]. Further-
more, silicon oxycarbide shows high temperature crystallization resistance [36]. Recently, the functional 
properties of silicon oxycarbide, such as electrical properties, optical properties and bioactivity, have 
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gained increasing attentions [32]. By varying the O:C atomic ratio or introducing additional elements into 
silicon oxycarbide, its properties can be adjusted. 
2.1.1. Polymer derived ceramic method 
In polymer derived ceramic (PDC) method, various Si-based ceramics are achievable by the thermolysis 
of Si-containing organic polymers in inert gas atmosphere [31, 37, 38]. Figure 2-1 summarizes the pol-
ymer precursors for PDC process. Thereafter, PDC method can be utilized for synthesizing silicon car-
bide (SiC), silicon oxycarbide (SiOC) and silicon carbonitride (SiCN). For silicon oxycarbide, polysilox-
ane and polysilsesquioxane are widely used precursors [39, 40]. 
 
Figure 2-1. Thermal decomposition of Si-based polymers and their corresponding ceramic products [38]. 
The polymer-to-ceramic transformation during the thermolysis undergoes several stages. At low tem-
peratures (100-400 °C), functional groups, such as ethoxy groups of the polymer precursors, crosslink 
to increase the molecular mass of polymer chain, reducing the mass loss related to molecule evapora-
tion [32, 37]. From 400 to 800 °C, the rearrangement of polymer molecules and the decompositions of 
organic groups occur accompanied by gas evolution of small molecules, such as CH4 and C2H4 [41, 42]. 
From 800 to 1000 °C, hydrogen content is still detectable in the derived ceramics and decreases con-
tinuously with increasing temperature [43-45]. After thermolysis at 1000 °C, the hydrogen in PDC-de-
rived silicon oxycarbide is removed extensively [46]. 1000 °C is thus considered generally as the tem-
perature, at which the polymer-to-ceramic transformation completes [32, 37]. 
The decomposition of carbon-containing organic groups leads to segregated carbon formation, i.e., so-
called “free carbon”. The content of “free carbon” in PDC-derived silicon oxycarbide is dependent on the 
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carbon content in its polymer precursor [47, 48]. At temperatures higher than 1200 °C, phase separation 
into SiC nanocrystalline and amorphous SiO2 occurs, followed by carbothermal reaction between formed 
SiO2 and “free carbon” according to equation (2-1) [16, 49]: 
 𝑆𝑖𝑂2(𝑠) + 3𝐶(𝑠) → 𝑆𝑖𝐶(𝑠) + 2𝐶𝑂(𝑔) (2-1) 
The ongoing carbothermal reaction leads to the decrease of “free carbon” content. Thus, at higher tem-
peratures (> 1400 °C) direct reactions (equation (2-2) [50]) between SiO2 and formed SiC is preferred, 
leading to gas evolution and a complete decomposition of silicon oxycarbide. 
 2𝑆𝑖𝑂2(𝑠) + 𝑆𝑖𝐶(𝑠) → 3𝑆𝑖𝑂(𝑔) + 𝐶𝑂(𝑔) (2-2) 
2.1.2. Structure of silicon oxycarbide 
Silicon oxycarbide contains corner-linked SiOxC4-x (x can be chosen from 0-4) building units [32]. NMR 
investigation of silicon oxycarbide shows no direct C-O bond, thus carbon can only bond to silicon or 
carbon itself [33]. In Figure 2-2 (a) a typical 29Si NMR spectrum of PDC-derived silicon oxycarbide can 
be deconvoluted into different SiOxC4-x building units. A quantitative assessment of the SiOxC4-x fractions 
via integration of the deconvoluted components exhibits significant deviation from the fractions calcu-
lated based on a statistically random distribution of Si-C and Si-O bonds [51]. Therefore, a concentration 
of SiOxC4-x units to carbon-rich SiC4 and oxygen-rich SiO4 units in silicon oxycarbide is confirmed [51]. 
Besides, the existence of “free carbon” (see Figure 2-2 (b)) is confirmed in various Raman investigations 
[40, 52]. In summary, silicon oxycarbide has an inhomogeneous microstructure, in which carbon-rich, 
oxygen-rich SiOxC4-x and “free carbon” domains coexist. 
Silicon oxycarbide is X-ray amorphous up to ca. 1300 °C [37, 50]. However, small-angle X-ray scattering 
(SAXS) investigation discovers a nano-domain structure with domain size of 1-3 nm in silicon oxycarbide 
[36], corresponding to the NMR and Raman investigations discussed above. At temperatures higher 
than 1300 °C, phase separation and carbothermal reaction in silicon oxycarbide lead to the observation 
of β-silicon carbide crystallization [49, 50]. The crystallization of amorphous SiO2 to cristobalite can occur 
at even higher temperatures (> 1500 °C) or after extra heat treatment [53]. The high crystallization re-
sistance for amorphous silica in silicon oxycarbide is related to residual Si-C bonds, “free carbon” in the 
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silica domains or formed fine phase separated nanostructure that prevent the nucleation of cristobalite 
[16, 49]. 
 
 
Figure 2-2. (a) Typical 29Si MAS NMR spectrum of polysiloxane derived silicon oxycarbide (solid bold 
line) with the simulated spectrum (dashed line) and individual simulation components (thin solid lines). 
The peaks (I, II, III, IV and V) correspond to SiO4, SiO3C, SiO2C2, SiOC3 and SiC4 units, respectively 
[51]; (b) TEM micrograph of a C-rich silicon oxycarbide sample synthesized at 1400 °C [54]. 
 
 
(a) 
(b) 
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Two models have been developed for the nano-domain structure in silicon oxycarbide. As shown in 
Figure 2-3 (a), Widgeon et al. [51] consider oxygen-rich SiOxC4-x regions to build a continuous matrix 
and “free carbon” particles are dispersed inside this matrix; in Figure 2-3 (b), Saha et al. [36] consider 
“free carbon” sheets or layers to build continuous cage walls that divide oxygen-rich SiOxC4-x regions 
(silica domains). In both models, carbon-rich SiOxC4-x regions sit between oxygen-rich SiOxC4-x and “free 
carbon” regions. The Widgeon’s model is supported by mass fractal analysis of oxygen-rich SiOxC4-x 
domains in silicon oxycarbide [51]; while the Saha’s model is based on the assumption that high creep 
resistance in silicon oxycarbide is related to a continuous “free carbon” network [36]. However, recent 
research results correlate the high creep resistance in silicon oxycarbide to domain-interfaces but not to 
the morphology of “free carbon” [34]. The low percolation threshold (i.e., 5 vol %) for “free carbon” in 
silicon oxycarbide is rather considered to be responsible for the formation of a continuous “free carbon” 
phase [55]. Thus, the microstructure of silicon oxycarbide should be described by a combination of these 
two models and both oxygen-rich SiOxC4-x and “free carbon” domains are continuous. 
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Figure 2-3. (a) Structural model of silicon oxycarbide, in which black regions represent “free carbon” and 
the patterned matrix is oxygen-rich silicon oxycarbide domains. Between the two regions lie the grey 
regions referring to carbon-rich silicon oxycarbide [51]; (b) Structural model of silicon oxycarbide, in 
which oxygen-rich silica regions are separated by “free carbon” sheets [36]. 
(a) 
(b)  
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2.1.3. Modification of silicon oxycarbide 
Additional elements are able to be introduced to silicon oxycarbide via chemical modification of its pol-
ymer precursor. The obtained so-called “single-source-precursor”, in which the doping elements are 
distributed homogenously on a molecular level, is converted subsequently to silicon oxycarbide via PDC 
process [32, 37]. 
Non-metallic elements, such as N and B, are incorporated into silicon oxycarbide network by forming 
covalent bonds. It has been reported that N forms N-C and N-Si bonds, and N-modification tunes the 
high temperature oxidation, crystallization and decomposition behavior of silicon oxycarbide [56-58]. B 
modification, forming B-C and B-O bonds in silicon oxycarbide, has been found to improve the “free 
carbon” ordering and β-SiC crystallization at high temperatures in silicon oxycarbide [59, 60]. 
Metallic elements, such as transition metals, tend to form in situ secondary phases in silicon oxycarbide, 
resulting in silicon oxycarbide based nanocomposites [37]. A systematic analysis by Ionescu et al. [17] 
implies an underlying thermodynamic control behind the formation of secondary phases. By considering 
high temperature carbothermal reaction, the formed metal-containing secondary phases can be pre-
dicted. Figure 2-4 shows that metals that are stable against carbothermal reaction tend to form oxide 
and silicate phases; while metals that are instable against carbothermal reaction tend to form metallic, 
metal silicide and metal carbide phases. Correspondingly, metal modified silicon oxycarbide combines 
the intrinsic properties of silicon oxycarbide matrix with functional properties of dispersed secondary 
phases. For example, Hf or Zr forms oxide phases in silicon oxycarbide, which have an effect on im-
proving high temperature stability [61, 62]; Sn forms metallic Sn phase in silicon oxycarbide and lends 
thus Si(Sn)OC material the property to uptake / release Li reversibly [63]; Fe forms iron silicide phases 
in silicon oxycarbide, leading to soft magnetic properties of Si(Fe)OC [64]. 
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Figure 2-4. Thermodynamically predicted phase composition of metal modified silicon oxycarbide 
(Si(M)OC) upon pyrolysis from 1100-1300 °C: Red-marked metals tend to form metal oxide or metal 
silicate phases in silicon oxycarbide; Blue-marked metals tend to form metallic, metal silicide, metal 
carbide phases in silicon oxycarbide due to carbothermal reaction [17]. 
 
Figure 2-5. Schematic illustration of Ca2+ and Mg2+ ions incorporation in silicon oxycarbide network at 
non-bridging-oxygen sites.  
Recently, the incorporation of alkali or alkaline earth metal ions, such as Mg2+, Ca2+ and Li+, at non-
bridging-oxygen (NBO) sites in silicon oxycarbide network has been reported [65, 66]. Besides, the 
introduction of Li+ into silicon oxycarbide leads to strong lithium silicate crystallization [65]. The breaking 
of covalent Si-O bonds upon formation of NBO sites as for Mg2+ and Ca2+ incorporation (see Figure 2-5) 
leads to a slight depolymerization of silicon oxycarbide network, which shows a significant effect on 
enhancing the bioactivity of silicon oxycarbide based biomaterial [21, 66]. 
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2.2. Biomaterials and bioactive glasses 
Biomaterial is defined as “material intended to interface with biological systems to evaluate, treat, aug-
ment or replace any tissue, organ or function of the body” [67]. Metals, polymers, ceramics and compo-
sites based biomaterials have found applications in surgery practice, for example, as implants or in 
medical devices [68]. The key criterion for biomaterials is their biocompatibility with host tissues in hu-
man body. Biocompatibility means that biomaterials are not cytotoxic and will not reduce cell viability 
[69]. Good biocompatibility can be achieved with materials that are chemically or physiologically inert 
such as Pt, Ti and Al2O3 [68, 70, 71]. The lack of corrosion and degradation of these materials in human 
body avoids possible cytotoxicity induced by degradation products and the change of physiochemical 
conditions at the host sites. 
On the other hand, the need for biodegradable or bioresorbable materials, such as biopolymers or hy-
drogels, is increasing, since new therapeutic solutions, such as temporary implant or drug delivery me-
dium, require materials that function by reacting with host tissues and disappear after fulfilling their pur-
poses [72]. Moreover, the disappearance of these materials after use eliminates the potential cytotoxicity 
of inert materials, which could take place due to material failure after a long-term service [69]. It is known, 
that biocompatibility of biodegradable materials depends strongly on their degradation mechanisms and 
the specific host responses during the degradation [69, 73, 74]. By adjusting the molecular structure of 
biodegradable materials, their biocompatibility can be tuned [75, 76]. 
Bioactive or bioreactive materials show bioactivity, which is defined as “phenomenon by which a bio-
material elicits or modulates biological activity” [67]. Since the discovery of Bioglass® 45S5 by LL Hench 
[2], the research of bioactive glasses is focused on bone repair application. Therefore, bioactivity of 
bioactive glasses is defined as the ability to trigger hydroxyapatite (Ca5(PO4)3OH) (HA) formation on 
material surface upon contact with human body fluid. Since HA is a bone mineral, the HA formation is 
correlated to a high bone-bonding ability [77, 78]. 
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2.2.1. Classification and mechanism of bioactivity 
Hench et al. [2] define two bioactivity classes: class B bioactivity induces osteoconduction, referring to 
bone formation along material surface; class A bioactivity induces both osteoproduction and osteocon-
duction. Osteoproduction refers to bone formation away from material surface, induced by the activation 
of osteoprogenitor cells to differentiate into osteoblast cells [2, 78]. This activation has been correlated 
to the release of Si and Ca from bioactive glasses, which triggers genetic cellular responses [79, 80]. 
Typical class A bioactive materials are bioactive glasses, while typical class B bioactive materials are 
bioactive ceramics, such as synthetic hydroxyapatite or tricalcium phosphate [81]. Due to the intracellu-
lar genetic activation, bioactive glasses have shown better bone regeneration effects than bioactive 
ceramics in in vivo studies [82, 83]. 
According to Hench et al [78, 81], the mechanism of bioactivity for bioactive glasses can be described 
in following steps: 
i. Ion exchange between glass network modifiers (Ca2+, Na+, etc.) and protons in body 
fluids leads to formation of surface silanol (Si-OH) groups; 
ii. The increase of local pH value due to ion exchange results in further hydrolysis of silica 
network and release of silicic acid (Si(OH)4) into body fluids; 
iii. Surface silanol groups condensate to form amorphous silica-gel surface layer, which is 
depleted of network modifiers; 
iv. Migration of Ca2+ and PO43- onto silica-gel layer, accompanied by ongoing glass disso-
lution, leads to formation of amorphous calcium phosphate; 
v. Surface calcium phosphate takes up OH- and CO32- from body fluids, leading to for-
mation of crystalline carbonated hydroxyapatite (HCA); 
vi. Adsorption and attachment of growth factors and stem cells (osteoprogenitor cell) to 
HCA layer. Further cell differentiation and proliferation result in new bone formation. 
Despite some critical arguments against the equalization of hydroxyapatite forming ability with bioactivity 
[84], the use of hydroxyapatite forming ability to compare the bioactivity of biomaterials has been estab-
lished [85-87]. Since the development and standardization of simulated body fluid (SBF) by Kokubo et 
al [88], in vitro assessment in SBF solution has become a routine method to evaluate bioactivity of 
biomaterials [89, 90]. SBF solution has nearly the same ion concentrations as human blood plasma. 
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The evaluation of apatite forming ability of biomaterials in SBF solution can be used to predict their 
bioactivity in vivo [91, 92]. 
Whether a silicate glass shows bioactivity, depends on its chemical composition. Hench et al. [13] 
investigated the bioactivity of SiO2-CaO-Na2O glass system by varying its chemical composition. As 
shown in Figure 2-6, 60 mol% has been found to be an upper limit for SiO2 content, in order to achieve 
bioactivity for melt-derived glasses [93]. The increase of alkali and alkaline earth metal content leads to 
fast glass dissolution and thus high bioactivity [94]. However, although alkali ions (i.e., Na) can improve 
apatite forming ability, they can also lead to high pH environment, which has caused certain cytotoxicity 
in in vivo studies [10, 95, 96]. Thus, the research on bioactive alkali-free glasses has been intensified. 
High bioactivity can be achieved for alkali-free glasses by tuning their glass network structure [9, 95, 97, 
98]. 
 
Figure 2-6. Kinetically determined boundaries for SiO2-CaO-Na2O glasses (with 6 wt.% P2O5). Depend-
ing on glass compositions, different bone-bonding behaviors (bioactivity) are to be expected [2]. 
Solid state NMR study of glass network structure shows a correlation between bioactivity and open 
network structure in bioactive glasses [3, 94]. By incorporating network modifiers such as Ca2+ and Na+ 
cations into silica network, the corner-connected SiO4 tetrahedra network is depolymerized. The break-
ing of parts of the Si-O covalent bonds is necessary in order to electrostatically balance the positive 
charges of the incorporated metal cations [99, 100]. The subsequent distribution of non-bridging-
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oxygens (NBO) in glass network results in Qn units, in which n is the number of bridging-oxygen on a 
network former atom and ranges from 0 to 4 for SiO4 tetrahedra [101]. Both Si and P are network formers 
in SiO2-P2O5 bioactive glasses. However, P forms orthophosphate units (PO43-) at low content and has 
thus only Qo units for 45S5 based bioactive glasses. Therefore, glass network connectivity (NC) is de-
fined as the average number of covalent bonds (e.g., bridging oxygen) on a Si tetrahedron and can be 
represented by the average n value for Si Qn units calculated by glass compositions according to equa-
tion (2-3) [101]: 
 𝑁𝐶 =
4[𝑆𝑖𝑂2] − 2[𝑀2
𝐼𝑂 +𝑀𝐼𝐼𝑂] + 6[𝑃2𝑂5]
[𝑆𝑖𝑂2]
 
(2-3) 
where MI and MII are alkali and alkaline earth metals, respectively; [SiO2], [MI2O], [MIIO] and [P2O5] rep-
resent their corresponding molar fractions. A direct evaluation of NC can also be done by applying Qn 
molar fractions calculated from 29Si NMR analysis according to equation (2-4): 
 𝑁𝐶 = ∑𝑛
4
𝑛=0
[𝑄𝑛] 
(2-4) 
where [Qn] refers to the molar fraction of Qn unit. Obviously, NC has a maximal value of 4 for quartz 
glass. The lower the NC value is, the more loosely the silica network is connected. Bioactive glasses 
have typical NC values between 2.0 and 2.6 [102]. At NC of ca. 2.0, Q2 units dominate glass network 
and build SiO4 tetrahedra rings that can be leached easily to aqueous solution, which is responsible for 
high bioactivity [100, 103]. The increase of SiO2 content increases network connectivity (see equation 
(2-3)), suppressing thus glass dissolution. In contrary, the increase of phosphorus content to a certain 
extent increases the content of easily soluble Q0 orthophosphate units, which are beneficial for enhanc-
ing bioactivity [101, 103]. Therefore, alkali-free bioactive glasses are achievable by replacing alkali ions 
with alkaline earth ions and in the meantime the network connectivity should be kept around 2.0. 
On the other hand, bioactivity is kinetically dependent since ion exchange occurs at the interface be-
tween solid and liquid. Therefore, bioactivity is influenced by specific surface area (SSA) of the materials. 
Traditional melt-derived silicate glasses have specific surface area valued under 3 m2/g, while sol-gel 
derived silicate glasses can reach specific surface area as high as 400 m2/g [89, 104, 105]. The increase 
of specific surface area enhances the bioactivity of silicate glasses and extends their composition range 
to show bioactivity. Sol-gel derived glasses with SiO2 content as high as 90 mol% can be highly bioactive 
[106, 107]. 
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2.2.2. Therapeutic effects of released ions 
 
Figure 2-7. Summary of therapeutic effects of released ions from bioactive glasses [4]. 
The process for new bone regeneration requires not only apatite forming ability, but also beneficial cel-
lular activation for bioactive materials [2, 84]. The dissolution products of bioactive glasses, i.e., released 
ions, play a crucial role on the cellular activation process and can tune angiogenesis, osteogenesis and 
antibacterial activity at host tissues, as summarized by Hoppe et al. (see Figure 2-7) [4]. 
The release of Si and Ca in appropriate rates can enhance osteogenesis. Si release has been reported 
to favor osteoprogenitor cell differentiation, osteoblast-like cell proliferation, collagen-I expression and 
formation of extracellular matrix [108, 109]. Thus, Si-substituted hydroxyapatite has shown higher bio-
activity than pure hydroxyapatite [110, 111]. Furthermore, Ca in extracellular environment improves the 
osteogenic differentiation of human dental pulp cells and human mesenchymal stromal cells, enhancing 
matrix mineralization [112, 113]. Meanwhile, the increase of intracellular Ca concentration suppresses 
bone resorption activity of osteoclasts [114]. As mentioned before, the class A bioactivity of Bioglass® 
is correlated to the osteogenic effects of released Si and Ca [2]. 
Mg has been reported to play a critical role in bone remodeling and skeletal tissue development, and 
can improve bone calcification and the attachment of osteoblast cell on biomaterial [115]. The increase 
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of Mg content in bioactive glasses can lower glass dissolution and thus apatite forming ability, since Mg 
is a network intermediate and can act as both network former and network modifier. Furthermore, Mg 
can enhance osteoblast cell proliferation [116]. The proliferation and differentiation of bone resorbing 
osteoclast cells may be suppressed at high Mg concentration [117]. 
Sr substitution in bioactive materials is a promising approach for treating osteoporosis disease [118]. By 
simultaneously enhancing metabolic activity of osteoblast cells (bone forming) and inhibiting that of os-
teoclast cells (bone resorbing) upon Sr2+ release, bone density can be enhanced [119, 120]. Moreover, 
in vivo studies of bioactive Sr-containing glasses or glass-ceramics confirm their high bone-bonding 
ability (osseointegration) [121, 122]. 
Surgery- and biomaterial-associated infections are due to the attachment of bacteria and the subsequent 
biofilm formation, which are difficult to be treated [123, 124]. ZnO nanoparticles show antibacterial ac-
tivity against various microorganisms. The mechanisms of such antibacterial properties are related to 
the disruption of cell membranes, production of reactive oxygen species, nanoparticle internalization 
into cells [125-127]. Meanwhile, the antibacterial effect upon Zn2+ release has been observed for 
Zn/ZnO-containing bioactive glass systems [128-130]. 
Angiogenesis, namely the revascularization process during new bone formation, is indispensable for 
bone tissue engineering [131]. The formation of blood vascular network allows the supply of oxygen, 
nutrients and growth factors to bone regeneration sites [132, 133]. Borate dissolution from boron-con-
taining bioactive glasses can stimulate the expression and secretion of vascular endothelial growth fac-
tor and improve thus angiogenesis [132, 134]. However, the concentration of released B plays an im-
portant role on cell viability. At high B concentration, cytotoxicity can occur [134]. A suitable B concen-
tration is achievable by controlling boron release kinetics [135]. 
In summary, ion release from bioactive glasses has diverse effects on cellular activity. At controlled 
release rate and thus suitable ion concentration, beneficial cellular responses for bone regeneration can 
be expected. Thus, composition design of bioactive glasses should not only target apatite forming ability, 
but also tailored ion release kinetics. 
 
  
  17 
2.2.3. Processing of bioactive glasses 
Bioactive glasses have high tendency to crystalize during thermal treatment due to their high content of 
alkali and alkaline earth metals. The processing window, namely the temperature range between glass 
transition temperature Tg and crystallization onset temperature Tc,o, lies between 520 °C and 652 °C for 
Bioglass® [11]. This narrow processing window brings difficulties for processing Bioglass® into monolith 
or scaffolds, since partial crystallization leads to local mechanical instability [78]. Although the formed 
crystalline phases, i.e., Na2CaSi2O6 and Na2Ca2Si3O9 depending on processing temperature [136, 137], 
are still able to induce apatite formation, their apatite forming ability is often lower [138, 139]. Moreover, 
the crystallization of bioactive glasses has been reported to inhibit protein adsorption and enforce inap-
propriate protein conformation for cell adhesion [140]. The efforts to enlarge the processing window in 
order to keep an amorphous glass nature during thermal processing are usually connected with an 
increase of glass network connectivity and thus lower apatite forming ability [3, 141]. 
 
Figure 2-8. Human nature femur bone, with in the inset the 3D porous structure of the cancellous bone 
scanned by X-ray microtomography [3]. 
As shown in Figure 2-8, human cancellous bone has a highly porous structure. Thus, synthetic scaffolds 
with large pore size (> 100 um) and high pore connectivity which can allow bone ingrowth and act as 
templates for new bone formation are highly desirable for bioactive materials [78, 142]. Typical methods 
for fabricating 3D scaffolds are polymer template, foaming, freeze-casting and additive manufacturing 
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methods [3, 143]. In polymer template method, polymer space holders or polymer foam templates with 
designed structure are used to form 3D scaffolds and removed after thermal annealing [144, 145]. In 
foaming process, gas bubbles induced by vigorous stirring are fixed in glass slurry via condensation 
reaction of the gelation additives. The bubbles are then left as pores in final scaffold [146, 147]. Freeze-
casting makes use of the growth of frozen solvent crystals to achieve an interpenetrating glass-solvent 
3D structure. After the removal of solvent via freeze-drying, a porous structure is achieved [148, 149]. 
Additive manufacturing emerges as a novel technique that is able to design the porous structure from 
the ground up. These methods are based on the processing of glass powder or slurry. Thus, the remain-
ing glass particles after processing need to be sintered through a following thermal stabilization / densi-
fication step. 
In order to solve the crystallization problem of Bioglass® scaffolds during their thermal densification [150, 
151], 13-93 bioactive glass (glass composition: Na2O 6.0 wt.%, K2O 12 wt.%, MgO 5 wt.%, CaO 20 
wt.%, P2O5 4 wt.% and SiO2 53 wt.%) has been developed [141]. 13-93 glass has a large processing 
window (592–932 °C) and its amorphous scaffold shows 20 times higher mechanical strength than Bio-
glass® scaffold fabricated in the same way [11, 12]. Meanwhile, although high mechanical strength can 
be achieved by designing oriented scaffold structure via freeze-casting or additive manufacturing tech-
niques [3, 12], the intrinsic brittleness of glass and ceramic materials remains a problem for sustaining 
cyclic bone loading. Therefore, bioactive polymer-glass composite has become a promising solution for 
fabricating clinically applicable scaffolds, which show high fracture toughness compared to pure glass 
scaffolds [3, 6, 12]. 
Moreover, bioactive glasses based coatings have been developed. Bioactive glass coating has been 
applied on SiC ceramic via pulsed laser ablation in order to achieve a high ceramic-bone bonding [152]. 
Biodegradable sutures coated with Ag-containing bioactive glasses show both bioactivity and antibac-
terial properties and are promising for tissue engineering and wound healing applications [153, 154]. 
Bioactive glass coating on zirconia substrate has significantly improved bioactivity compared to un-
coated zirconia substrate [155]. Furthermore, the thermal expansion coefficient of bioactive glasses can 
be adjusted, in order to achieve a high bonding strength between glass coating and substrate material 
[156-158]. Thus, the processing of bioactive glasses into coating is a promising method to combine the 
high bioactivity of bioactive glasses with the high mechanical properties of substrate materials. 
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2.3. Silicon oxycarbide for prospective biomedical applications 
The unique PDC synthesis method provides a high possibility to tune material morphology, composition 
and microstructure of silicon oxycarbide according to the intended application [32]. Moreover, the com-
bination of the existence of segregated “free carbon”, high crystallization resistance and high mechanical 
properties in silicon oxycarbide makes it a promising material to substitute silicate or carbon based ma-
terials for various biomedical applications. Although the research work on the biomedical properties of 
silicon oxycarbide is still limited, its prospective biomedical applications have been highlighted in some 
preliminary studies, as being summarized in Figure 2-9. In the following sections, the biomedical prop-
erties of silicon oxycarbide will be reviewed based on published research results and are categorized 
into biocompatible, bioactive or surface active properties. 
 
 
 
Figure 2-9. Summary of the biomedical applications of silicon oxycarbide materials in published research 
work. 
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2.3.1. Biocompatibility of silicon oxycarbide 
Blood contact properties 
Silicon oxycarbide is a versatile blood contact material. By incorporating carbon, the propensity of silicon 
oxycarbide to blood coagulation can be tuned between that of procoagulant silica and hemocompatible 
pyrolytic carbon. The hemocompatibility of PDC-derived silicon oxycarbides with different O and C con-
tents has been evaluated via coagulation time in human recalcified platelet poor plasma (PPP) test, 
which shows a clear correlation between hemocompatibility and surface C/O atomic ratio, namely, high 
C/O atomic ratio can improve hemocompatibility to the level of inert silanized glass [159]. At the same 
time, blood contact tests on CVD-derived silicon oxycarbide nanowires with low carbon content (13.4 
at.%) have shown promoted platelet activation similarly to flat silicon dioxide samples in porcine platelet 
rich plasma (PRP) test. Kinetic analysis of hemoglobin released from erythrocytes confirmed even 
stronger blood clotting formation for silicon oxycarbide nanowires than flat silicon dioxide samples [18]. 
Thus, despite carbon incorporation, the silicon oxycarbide nanowires do not show improved hemocom-
patibility, which could be related to the relatively low carbon content. However, since carbon exists in 
both sp3 and sp2 bonding states in silicon oxycarbide, a separation of these two contributions to blood 
contact properties still needs to be done in future research. 
Properties for medical electrodes 
Silicon oxycarbide is a promising material for medical electrodes in implantable pacemakers or neu-
rostimulators, in which electrical stimulation is used to treat cardiac or cortical diseases [160, 161]. Elec-
trodes made of conductive metals show degradation in human physiochemical environment, which low-
ers their life time and leads to local inflammation or fibrotic tissue growth [162]. Since silicon oxycarbide 
has high chemical durability in acidic and basic environments, it is a suitable material for fabricating 
protective layers for metal electrodes [163, 164]. Besides, silicon oxycarbide materials have a broad 
range of electrical conductivity values, which could be tuned via conductive doping or by adjusting its 
“free carbon” content [19, 165, 166]. Kaspar et al. [167] reported relatively high electrical conductivity of 
2.3 S/m for silicon oxycarbide with 54.2 wt.% “free carbon” content. Silicon oxycarbide materials have 
thus the potential to be applied as biomedical electrodes. Perale et al. [168] fabricated silicon oxycarbide 
filaments via micro-co-extrusion of polymer precursors, and reached with 50 wt.% carbon black doping 
an electrical conductivity of about 0.4 S/m. Although still no specific biomedical research of silicon ox-
ycarbide electrodes has been reported, conductive medical electrodes based on silicon oxycarbide are 
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promising substitutes for metal electrodes thanks to the high physiochemical stability and the processing 
advantages of silicon oxycarbide materials via polymer precursors. 
Non-cytotoxic properties 
Silicon oxycarbide is a non-cytotoxic substrate material. Hoppe et al. [4] summarized two methods for 
assessing the cellular response to biomaterials. In the indirect method, the cell viability is assessed in 
cell cultivation solutions, which are conditioned with biomaterial leaching products. And there is no direct 
contact between cells and biomaterial. In the direct method, cells are seeded directly on biomaterial 
surfaces and thus the material surface characteristics (e.g., surface topography, porosity) have a direct 
influence on cell growth and proliferation. 
The biocompatibility of silicon oxycarbide has been extensively investigated by different cell culture 
tests. As shown in Table 2-1, the released species from ternary silicon oxycarbide have been shown to 
be non-cytotoxic in all investigated cases. However, in some tests, evaluation of cell markers when cells 
were attached to silicon oxycarbide monoliths or coatings has shown reduced cell viability compared to 
the control (usually polystyrene, titanium or cover glass). Silicon oxycarbide monoliths and coatings 
derived from polymer precursors undergo thermolysis with gas evolution during their conversion to sili-
con oxycarbide. Thus, if not polished, the surface morphology of silicon oxycarbide is expected to have 
high roughness and porosity, differing from that of the control surfaces polystyrene, titanium and cover 
glass slides. Since cell adhesion is influenced by surface morphology [169], an unsuitable surface rough-
ness could be the reason for the reduced cell viability on silicon oxycarbide specimens, as also stated 
by Gaweda et al [20]. On the other hand, several studies found out that a high polar surface energy is 
beneficial for the cell adhesion [170-172]. Silicon oxycarbide is reported to have much higher dispersive 
surface energy than vitreous silica [173], which could also lead to an unfavorable surface energy (com-
prising both polar and dispersive parts) situation for cell attaching. Therefore, direct cellular tests on 
silicon oxycarbide monolith samples and coatings are challenging as such tests require the surface to 
be conditioned for improved protein and cell adhesion. 
Furthermore, since the publication of Ca/Mg modified silicon oxycarbide by Gonzalo-Juan et al [21], an 
innovative approach is receiving attention, namely the modification of silicon oxycarbide with therapeutic 
ions (such as Ca, Zn, Sr, etc.), which should enhance the potential to achieve high bioactivity of silicon 
oxycarbide or to induce specific healing or therapeutic effect by the controlled release of such ions [4]. 
Research work on this kind of modified silicon oxycarbide materials is still in its infancy but it is expected 
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to increase, given the high potential of ion releasing inorganic materials for bone and soft tissue engi-
neering [79, 174, 175]. 
Table 2-1. Summary of cytotoxic investigations on silicon oxycarbide materials in literature. 
Material 
form 
Sample infor-
mation 
Test 
method 
Test cell Result Ref. 
Nanowires 
(ca. 100 nm 
diameter) 
CVD derived SiOC 
(Si1O1.42C0.37) nan-
owires on Si sub-
strate 
Indirect/ 
Direct 
L929 cells 
No cytotoxic effect could be 
found in indirect test. Higher cell 
viability, cyclin D1 transcript on 
nanowires than on flat silica at 
long testing time (96 h) in direct 
test. 
[18] 
Disc (3 cm 
diameter) 
Polymethylsiloxane 
derived (1200 °C in 
N2) SiOC  
Direct 
MG-63 
cells; L929 
cells 
Cell proliferation on SiOC disc 
comparable to tissue culture 
plastic control. 
[19] 
Coating on 
Ti substrate 
Silsesquioxane de-
rived (800 °C in Ar-
gon) SiOC  
Direct 
MG-63 
cells 
Comparable cell number (LDH 
activity) on coating to that on Ti 
and polystyrene. 
Lower cell viability (mitochon-
drial activity) on coating than on 
Ti or polystyrene references, in-
dicating negative surface influ-
ence. 
[20] 
Monolith 
Polysilsesquioxane  
derived (1100 °C in 
Argon) SiOC  
Direct  MEF cells  
Significantly reduced cell viabil-
ity on SiOC than on polystyrene 
and cover glass. 
[21] 
Powder 
Polysilsesquioxane/ 
Vinyl-containing 
polysiloxane de-
rived (1100 °C in 
Argon) SiOC (SSA: 
ca. 20 m2/g) 
Indirect 
HEK-293 
cells 
Slightly reduced cell viability at 
high solid loadings. 
Residual “fee carbon” does not 
affect the cytotoxicity. 
[21] 
Mesoporous 
powder 
Sol-gel (siloxane) 
derived SiOC 
(SSA: ca. 450 
m2/g) 
Indirect 
MT-2 cell; 
HEC-1-A 
cells  
No cytotoxic effect could be ob-
served. 
[176] 
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2.3.2. Bioactivity of silicon oxycarbide 
The research work on the bioactivity of silicon oxycarbide materials is limited until now. Gaweda et al. 
[20] prepared silicon oxycarbide coating (about 1 um thick) on Ti substrate via dip-coating method. The 
coated substrates were tested in SBF solution for 5 weeks, during which every week the SBF solution 
was refreshed. It has been found out that hydroxyapatite forms preferentially on silicon oxycarbide coat-
ings with low carbon content [20]. The morphology of formed hydroxyapatite is correlated to the varying 
carbon content and surface roughness [20]. 
Gonzalo-Juan et al. [21] investigated silicon oxycarbide materials in SBF solution under stirring for dif-
ferent time periods. Ternary silicon oxycarbide has shown no hydroxyapatite formation after 2 weeks 
testing; whereas, Ca and Mg modified silicon oxycarbide glass (chemical composition: 
Si1Mg0.07Ca0.05O1.73C0.96) has high hydroxyapatite forming ability (hydroxyapatite formation after already 
3 days), confirmed by a decrease of calcium and phosphorus concentration in the solution [21]. This 
enhancement of silicon oxycarbide bioactivity by Ca and Mg modification is correlated to the network 
modifier effect: calcium is network modifier and magnesium is network intermediate (act as both network 
former and network modifier) [3]. As mentioned in section 2.2.1, the incorporation of network modifier in 
silicate glasses lowers network connectivity, increasing glass dissolution and thus bioactivity. Ionescu 
et al. [66] made a systematic investigation of the network structure in Ca and Mg modified silicon ox-
ycarbide. Ca and Mg modification lead to the formation of Si Q3 units, and lower the content of network 
carbon [66]. Both factors are responsible for the good bioactivity of Ca and Mg modified silicon oxycar-
bide [66]. Furthermore, the unique nano-domain structure of silicon oxycarbide (see section 2.1.2) may 
also play a role on the bioactivity of silicon oxycarbide. 
In summary, the research work until now has proven apatite forming ability of ternary silicon oxycarbide 
upon SBF immersion. This apatite formation is very slow and can take as long as 5 weeks. A much 
faster apatite formation is achievable upon incorporating network modifiers into silicon oxycarbide net-
work architecture. 
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2.3.3. Silicon oxycarbide based surface active materials 
Antibacterial surface material  
By introducing Ag doping, silicon oxycarbide can attain antibacterial properties. Khalilpour et al. [177] 
reported Ag/SiOxCy plasma antimicrobial coatings on stainless steel. Ag nanoparticles (5-50 nm) cov-
ered in chemical vapor deposited (CVD) silicon oxycarbide layer could be continuously released and 
thus the surfaces exhibited excellent antimicrobial activity against Methicillin-resistant Staphylococcus 
aureus (MRSA). Guo et al. [178] proposed Ag/SiOC composite fibers fabricated via electro-spinning of 
polymethylsilsesquioxane and silver oxide nanoparticles or silver acetate co-solution. The formation of 
Ag nano/micro-particles after thermolysis led to antibacterial effects against Gram-negative Escherichia 
coli bacteria and Gram-positive Staphylococcus aureus bacteria. By introducing ZnO nanoparticles into 
silicon oxycarbide polymer precursor, ZnO doped silicon oxycarbides could be synthesized after ther-
molysis in argon and they exhibited enhanced photocatalytic activity compared to ternary silicon oxycar-
bide [179]. As mentioned in section 2.2.2, ZnO nanoparticles and Zn-containing bioactive glasses can 
show antibacterial properties. ZnO doped silicon oxycarbide could thus also be antibacterial. Therefore, 
silicon oxycarbide based antibacterial materials can be developed via antibacterial ion doping. Unlike 
silicate glasses, in which ion doping and homogenization happen at glass melting temperature and the 
amount of doping ions is limited by the glass melting properties, such as devitrification, ion doping and 
homogenization in silicon oxycarbide can be conducted on polymer precursor at room temperature. 
Drug delivery material 
Mesoporous materials are promising for drug delivery, since their high porosity, specific surface area 
and pore volume provide sufficient capacity for the adsorption of drug molecules. Besides, the possibility 
to adjust their pore structure and conduct surface functionalization is beneficial for achieving targeted 
drug release, which is desirable in modern medicine [180]. Furthermore, mesoporous silicon oxycarbide 
based biomaterials are suitable material candidates for drug delivery application due to their high bio-
compatibility (see section 2.3.1). Tamayo et al. [176] synthesized mesoporous silicon oxycarbide via 
sol-gel process. The obtained silicon oxycarbide materials show a bimodal pore size distribution at 6 nm 
and 70 nm with SSA as high as 442 m2/g. The observed loading capacity of acyclovir drug is higher than 
that of mesoporous silica. This improved drug loading is correlated to additional surface carbon func-
tional groups on silicon oxycarbide [176]. The same research group performed a systematical investi-
gation of the dispersive surface free energy of silicon oxycarbide materials and found that their surface 
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is more similar to that of graphitic materials, rather than that of vitreous silica. Their high dispersive 
surface energy is correlated to structural heterogeneities in molecular size, which originate probably 
from graphitic carbon layers on silicon oxycarbide surface (see section 2.1.2) [173]. Thus, the unique 
heterogeneous silicon oxycarbide surface, comprising both graphitic “free carbon” and oxygen-rich Si-
OxC4-x domains, allows two surface modification strategies: either the functionalization of silicon oxycar-
bide surface silanol groups with γ-aminopropyl trimethoxy silane or the introduction of carbonyl and 
carboxylic functionalities to silicon oxycarbide surface via chemical oxidation of surface “free carbon” 
can influence the adsorption and release kinetics of acyclovir significantly [176, 181]. 
Furthermore, hierarchical pore structure in silicon oxycarbide is achievable via HF etching. 
Vakifahmetoglu et al. [182] synthesized silicon oxycarbide with a bimodal pore size distribution at < 5 
nm and 10-20 nm. The micropores (< 5 nm) show higher bovine serum albumin loading capacity than 
mesopores [182]. Interestingly, Tamayo et al. [176] find that the silanol modification processes prefer-
entially inside mesopores. This pore size dependent affinity of drug or surface modifier implies the po-
tential of hierarchical pore structure in silicon oxycarbide materials to be applied for multidrug delivery 
systems. Meanwhile, by applying novel processing method mesoporous hollow silicon oxycarbide cap-
sules with a diameter of ca. 400 nm and a thickness of ca. 40 nm have been synthesized [183]. Their 
mesoporous shell allows the penetration of drug into the inside hollow spaces and their capsule structure 
promises for a controlled release [183]. The diameter or thickness of such capsules can be adjusted 
according to need [184]. Such flexibility in designing porous silicon oxycarbide is beneficial for its poten-
tial drug delivery applications. 
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3. Experimental Procedure 
3.1. Material preparation 
3.1.1. PMS derived silicon oxycarbide 
A commercially available polymethylsilsesquioxane (PMS) with functional ethoxy groups (Silres® MK 
powder, Wacker, Munich, Germany) was mixed and ground in an mortar with calcium acetylacetonate 
(Ca(acac)2, Sigma Aldrich, Munich, Germany), boric acid (H3BO3, Sigma Aldrich, Munich, Germany) 
and/or strontium acetylacetonate (Sr(acac)2, Sigma Aldrich, Munich, Germany) according to the set mo-
lar ratios at room temperature to achieve homogenous mixtures. All mixtures were cross-linked at 250 
°C for 4 h and subsequently pyrolyzed in argon flow at 1100 °C for 3 h, as shown in the pyrolysis program 
in Figure 3-1. The achieved black samples were ground into powders. The amounts of chemicals for 
preparing the powder mixtures and the sample names before and after pyrolysis are listed in Table 3-1. 
Table 3-1. The amounts of Silres® MK, calcium acetylacetonate, boric acid and strontium acety-
lacetonate used for the preparation of the precursor mixtures and the corresponding molar ratios. 
Precursor mix-
ture 
Pyrolyzed sam-
ple 
Silres® MK 
(g) 
Ca(acac)2 
(g) 
H3BO3 
(g) 
Sr(acac)2 
(g) 
Molar ratio 
MK SiOC 2 - - - - 
MK-B7 SiOC-B7 2 - 0.12 - B/Si=0.07 
MK-Ca5 SiOC-Ca5 2 0.36 - - Ca/Si=0.05 
MK-B7Ca5 SiOC-B7Ca5 2 0.36 0.12 - 
B/Si=0.07, 
Ca/Si=0.05 
MK-Ca12 SiOC-Ca12 2 0.87 - - Ca/Si=0.12 
MK-
B7Ca5Sr0.8 
SiOC-
B7Ca5Sr0.8 
2 0.36 0.12 0.07 
B/Si=0.07, 
Ca/Si=0.05, 
Sr/Si=0.008 
MK-B7Ca5Sr4 
SiOC-
B7Ca5Sr4 
2 0.36 0.12 0.33 
B/Si=0.07, 
Ca/Si=0.05, 
Sr/Si=0.04 
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Figure 3-1. Pyrolysis program for PMS derived silicon oxycarbides.  
3.1.2. Sol-gel derived silicon oxycarbide 
Triethoxymethylsilane (CH3Si(OC2H5)3, Alfa Aesar, Kandel, Germany) and calcium nitrate tetrahydrate 
(Ca(NO3)2·4H2O, Carl Roth, Karlsruhe, Germany) were mixed with nitric acid solution (0.01 M) and 
stirred until a homogeneous sol was formed. By adjusting the sol to pH ≈ 9.0 with ammonia solution (1 
M) titration, the gelation process set in and the obtained gel was aged at 60 °C and subsequently dried 
at 120 °C. The complete sol-gel process was depicted in Figure 3-2. By varying the amount of calcium 
nitrate tetrahydrate, four different xerogels could be prepared with corresponding Ca/Si molar ratios of 
0.00, 0.05, 0.12 and 0.50 and they were denoted as SG-Ca0, SG-Ca5, SG-Ca12 and SG-Ca50, respec-
tively, as shown in Table 3-2. 
Table 3-2. Amounts of chemicals for sol-gel procedure. 
Xerogel 
Pyrolyzed 
sample 
Molar ratio 
(Ca/Si) 
Triethoxyme-
thylsilane (g) 
0.01M HNO3 
Solution (g) 
Ca(NO3)2·4H2O 
(g) 
SG-Ca0 SiCa0 0.00 10 3.0 0.00 
SG-Ca5 SiCa5 0.05 10 3.5 0.66 
SG-Ca12 SiCa12 0.12 10 4.0 1.59 
SG-Ca50 SiCa50 0.50 10 4.5 6.62 
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1100 °C for 3 h 
Time 
250 °C for 4 h 
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Figure 3-2. Sol-gel procedure for silicon oxycarbide xerogel precursors. 
 
Figure 3-3. Pyrolysis program for sol-gel derived silicon oxycarbides.  
The xerogel samples were ground to powder and then pyrolyzed at 1100 °C in argon flow to silicon 
oxycarbide materials according to the pyrolysis program in Figure 3-3. During the heating stage, a hold-
ing time of 2 h at 600 °C was conducted, in order to eliminate the remaining nitrate groups from calcium 
nitrate. The obtained silicon oxycarbide materials were ground to powder for further analysis and the 
samples derived from SG-Ca0, SG-Ca5, SG-Ca12 and SG-Ca50 were denoted as SiCa0, SiCa5, 
SiCa12 and SiCa50, respectively. 
Triethoxymethylsilane 
0.01 M HNO3 solution 
Ca(NO3)2·4H2O 
Sol 
Ca(NO3)2 solution 
Stirring 
Gel 
Add Ammonia solu-
tion to pH ≈ 9.0 
Aged Gel Xerogel 
60 °C for 3 days 120 °C for 3 days 
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1100 °C for 3 h 
Time 
600 °C for 2 h 
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3.2. Bioactivity assessment 
3.2.1. Simulated body fluid 
Acellular bioactivity tests were performed by exposing the powder samples to the simulated body fluid 
(SBF). The simulated body fluid was prepared according to Kokubo [88]. The preparation procedure 
was conducted according to ISO 23317: 700 ml deionized water was filled in an 1 L plastic bottle and 
heated up to 37 °C; the reagents were then added according to the steps listed in Table 3-3; Tris was 
added in small portions to avoid rapid pH increase; after a pH value of 7.45 was reached, the solution 
was transferred to an 1 L volumetric flask and diluted with deionized water to 1 L. The precipitation-free 
SBF solution was then stored in a cool environment. Before use, its pH value was adjusted with 1-2 ml 
of 1 M HCl solution to be 7.40 at 37°C. 
Table 3-3. Reagents for the preparation of SBF solution. 
Step Reagent Amount for 1 L SBF Purity and provider 
1 NaCl 8.035 g ≥99.0%, Sigma Aldrich 
2 NaHCO3 0.355 g ≥99.7%, Sigma Aldrich 
3 KCl 0.225 g ≥99.0%, Sigma Aldrich 
4 K2HPO4·3H2O 0.231 g ≥99.0%, Merck 
5 MgCl2·6H2O 0.311 g ≥99.0%, Merck 
6 1M HCl 38 ml 
Diluted from 37% HCl Solution, 
Sigma Aldrich 
7 CaCl2·2H2O 0.386 g ≥99.0%, Merck 
8 Na2SO4 0.072 g ≥99.99%, Sigma Aldrich 
9 Tris(hydroxymethyl)aminomethane Ca. 6.0 g ≥99.8%, Sigma Aldrich 
3.2.2. TC04 method 
The in vitro bioactivity tests were done based on the TC04 (Technical Committee on Bioglasses) method 
reported by Macon et al [89]. The solid powder to SBF solution ratio was fixed at 75 mg to 50 ml. After 
the mixture of solid powders with SBF solution in airtight poly-ethylene (PE) bottles, the incubation was 
conducted at 37 °C in a drying oven. Different test periods (4 h, 8 h, 24 h, 72 h, 1 week, 2 weeks, 3 
weeks, 4 weeks) were chosen for each sample. Additionally, 72 h soaking tests were carried out at 24 
°C and 55 °C. At the end of each period, solid powders were separated from SBF solution via filtration. 
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The filtered powders were washed with deionized water and acetone and subsequently dried at 40 °C. 
For comparison purposes, a commercially available bioactive glass with 45S5 composition (45 wt.% 
SiO2, 24.5 wt.% CaO, 24.5 wt.% Na2O, 6.0 wt.% P2O5) (Vitryxx® Bioactive Glass, Schott, Mainz, Ger-
many) was chosen for the SBF test. 
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3.3. Material characterization  
3.3.1. Elemental analysis 
The carbon and oxygen contents of pyrolyzed silicon oxycarbide samples were determined by a carbon 
analyzer Leco-200 (Leco Corporation, St. Joseph, USA) and a N/O analyzer Leco TC-436 (Leco Cor-
poration, St. Joseph, USA), respectively. Sorarù et al. [46] reported the hydrogen contents of silicon 
oxycarbides pyrolyzed at 1000 °C to be lower than 0.3 wt.%. Hydrogen contents in silicon oxycarbide 
samples of the present work (pyrolyzed at 1100 °C) were thus considered to be negligible. The calcium 
and boron contents for SiOC-B7Ca5 and SiOC-B7 samples were measured via inductively coupled 
plasma – optical emission spectroscopy (ICP-OES) at Mikroanalytisches Labor Pascher (Remagen, 
Germany). The silicon content was determined by subtracting carbon, oxygen, calcium and boron con-
tents from 100%. 
3.3.2. Thermogravimetric analysis with evolved gas analysis 
The polymer-to-ceramic transformation of the prepared polymer precursors was investigated with ther-
mogravimetric analysis (TGA, Netzsch 449C Jupiter®, Selb, Germany) coupled with in situ evolved gas 
analysis (EGA), i.e., via mass spectrometry (Netzsch QMS 403C Aeolos®, Selb, Germany) and FTIR 
spectroscopy (Bruker Tensor 27, Billerica, USA). The investigation was conducted by Dipl.-Ing. Claudia 
Fasel in the working group of Prof. Ralf Riedel at the Technical University of Darmstadt. The measure-
ments were performed in argon flow (30 ml/min) with a heating rate of 5 °C/min to 1300 °C.  
3.3.3. X-ray diffraction 
X-ray powder diffraction was performed with a STOE STADI P (STOE, Darmstadt, Germany) equipped 
with Mo Kα X-ray source, Ge(111) monochromator and linear position sensitive detector (PSD) in trans-
mission geometry in a 2θ range of 5-45° and the diffractograms were analyzed with crystallographic 
program MATCH!. 
3.3.4. Fourier-transform infrared spectroscopy 
FTIR spectroscopy measurements were carried out on a Varian IR-670 spectrometer (Agilent, Santa 
Clara, USA) from 400 to 4000 cm-1. Powder samples were mixed with KBr powder in a concentration of 
0.2-1 wt.% (0.2 wt.% for organic materials, 1 wt.% for inorganic materials), and then pressed to trans-
parent or translucent thin pellets (ca. 1 mm thick) with a diameter of 12 mm prior measurements. 
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3.3.5. Transmission electron microscopy 
The transmission electron microcopy (TEM) investigation was conducted by M.Sc. Maximilian Trapp in 
the working group of Prof. Hans-Joachim Kleebe at the Technical University of Darmstadt. For the TEM 
studies, powder samples were prepared on copper TEM-grids with a supporting holey carbon film (400 
mesh, Plano, Wetzlar, Germany). The samples were lightly carbon coated (Med 010, Balzers Union, 
Balzers, Liechtenstein) to minimize charging effects under the incident electron beam. The TEM inves-
tigations were performed on a JEOL JEM 2100F (JEOL, Tokyo, Japan) equipped with a TEM 250 SDD 
energy dispersive spectroscopy (EDS) system (Oxford Instruments, Wiesbaden, Germany). 
3.3.6. Scanning electron microscopy 
Powder samples were loaded onto carbon pads on aluminum sample holders and subsequently sput-
tered lightly with gold. The surface morphologies of the samples were investigated by scanning electron 
microscopy (SEM) (JEOL JSM-7600F, Tokio, Japan). 
3.3.7. Solid state nuclear magnetic resonance 
The solid state nuclear magnetic resonance (NMR) measurements were conducted by Dr. Hergen 
Breitzke in the working group of Prof. Gerd Buntkowsky at the Technical University of Darmstadt. 11B 
and 29Si MAS solid state NMR measurements were carried out at room temperature on a Bruker 
AVANCE II+ spectrometer (Bruker, Billerica, USA) at 400 MHz proton resonance frequency, employing 
a Bruker 4 mm double resonance probe. 29Si spectra were recorded utilizing Bruker ZG sequence at 
spinning rates of 8 kHz, and pulse angles of 22°, and 120 s relaxation delay. During data acquisition 
TPPM (Two pulse phase modulation) decoupling with a 15° phase jump was applied [185]. 29Si Spectra 
were referenced externally to tetramethylsilane (TMS) at 0 ppm. 11B spectra were recorded utilizing the 
EASY background suppression sequence, applying 30° excitation pulse and 2 s relaxation delay [186]. 
The EASY sequence was modified with respect to the background suppression part, by including an 
additional 90° pulse and delay of 10 ms before the background subtraction part of the sequence. 11B 
spectra were referenced externally to BF3.OEt2 at 0 ppm. 
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3.3.8. Laser particle size analysis 
The particle sizes of the powder samples were analyzed with a Laser Particle Sizer (Fritsch Analysette 
22 Compact, Idar-Oberstein, Germany). The powders were dispersed in deionized water using an ultra-
sonic bath (3 minutes) and then measured in a transparent chamber under continuous circulation. 
3.3.9. Zeta potential analysis 
Powder samples were dispersed in deionized water (pH ≈ 5.0 at room temperature), and the zeta po-
tential of the solid-liquid interface was measured using the Smoluchowski equation [187] (Zetasizer 
Nano-ZS, Malvern Instruments, Kassel, Germany). As reference, the zeta potential of synthetic hydrox-
yapatite powder (HA) (Sigma Aldrich, Munich, Germany) was measured in deionized water, too. 
3.3.10. Inductively coupled plasma - optical emission spectroscopy analysis 
The pH values of the filtered SBF solutions were measured and the solutions were used for inductively 
coupled plasma - optical emission spectroscopy (ICP-OES) analysis. For the ICP-OES measurements, 
the solutions were diluted up to 200 times and the Si, Ca, P and Sr concentrations in diluted solutions 
were analyzed with an Agilent 720 ICP-OES (Agilent, Santa Clara, USA) spectrometer. The ICP-OES 
measurements were conducted by Dipl.-Geol. Christian Scholz in the working group of Prof. Margot 
Isenbeck-Schröter at the Heidelberg University. 
3.3.11. N2 sorption analysis 
The specific surface area of powder samples was investigated by nitrogen sorption (QuantaChrome 
Autosorb-3B, Graz, Austria). All samples were degassed at 180-200 °C for 20-24 h to remove surface 
adsorbates before the analysis. Adsorption curves of obtained isotherms were fitted via 7 points (relative 
pressures of 0.05-0.3) with the Brunauer-Emmett-Teller (BET) equation [188] to determine their specific 
surface area. Pore size distributions of the samples were evaluated by BJH method on the desorption 
part of the isotherms [189]. 
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4. Results and Discussion 
4.1. PMS derived Si(B,Ca)OC bioactive materials 
Si(B,Ca)OC silicon oxycarbide materials were synthesized from polymethylsilsesquioxane (PMS) based 
precursors which were modified with boric acid and/or calcium acetylacetonate (see Table 3-1). In the 
following sections, the polymer-to ceramic transformation of the polymer precursors will be discussed 
according to the thermogravimetric analysis. The microstructure and network architecture of achieved 
Si(B,Ca)OC samples were analyzed with X-ray diffraction (XRD), Fourier-transform infrared spectros-
copy (FTIR), transmission electron microscopy (TEM) and solid state nuclear magnetic resonance 
(NMR). The bioactivity of Si(B,Ca)OC in simulated body fluid (SBF) is assessed according to their ion 
release kinetics and apatite forming ability, and compared to that of a commercial bioactive glass with 
45S5 composition. The correlation between bioactivity and structural features, especially the network 
architecture of the Si(B,Ca)OC materials will be discussed at the end. 
4.1.1. Polymer-to-ceramic transformation 
The polymer to ceramic transformations of MK, MK-B7, MK-Ca5, MK-B7Ca5 and MK-Ca12 (see Table 
3-1) were studied with thermogravimetric analysis (TGA) coupled with evolved gas analysis (EGA). The 
ceramic yields are given in Figure 4-1 (a). The higher weight loss of B and/or Ca-containing precursors 
as compared to that of the non-modified polymer is due to the decomposition reaction of H3BO3 and 
Ca(acac)2 during the ceramization. The assignment of IR signals to degassing species was conducted 
by Dipl.-Ing. Claudia Fasel. Figure 4-1 shows the intensity evolution of specific IR-traces with tempera-
ture of different degassing species during ceramization. 
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Figure 4-1. (a) Thermogravimetric (TGA) curves for MK (black line), MK-B7 (green line), MK-Ca5 (red 
line), MK-B7Ca5 (blue line) and MK-Ca12 (orange line). The characteristic peaks of the evolved gas 
species are determined via in situ FTIR to be located between 758-787 cm-1 for C8H24O12Si8, 3638-3689 
cm-1 for C2H6O, 1709-1763 cm-1 for C3H6O, 1594-1651 cm-1 for C5H8O2, 1454-1546 cm-1 for H2O, 948-
952 cm-1 for C2H4 and 3011-3019 cm-1 for CH4. The individual TG curves and in situ recorded signal 
intensities of the characteristic IR peaks are shown in (b), (c), (d), (e), and (f), respectively. 
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At temperatures beyond 400 °C, the main degassing species are CH4 and C2H4 for all investigated pre-
cursors. Silres® MK polymer has methyl groups, which are split off from the polymer network at these 
temperatures.  
At temperatures below 400 °C, the nature of the released species depends on the precursor used (i.e., 
on the chemical modification of the polymethylsilsesquioxane). The evolution of polyhedral oligomeric 
silsesquioxane (POSS – C8H24O12Si8) was observed for pure MK polymer and not for precursors with 
modifiers, indicating the better stabilization of small polymer molecules via modifying reactions [62]. 
Ethanol (C2H6O) release indicates the reaction between ethoxy groups (in polymer) and hydroxyl 
groups. In MK-B7, the release of ethanol is more significant than that in MK, and is considered to be a 
consequence of the modification with H3BO3 (see Figure 4-2). In MK-Ca5, MK-B7Ca5 and MK-Ca12, 
ethanol release is suppressed, whereas acetylacetone (C5H8O2) and acetone (C3H6O) outgassing dom-
inates, being correlated to the presence of acetylacetonate groups in the Ca precursor [190-192]. In MK-
B7Ca5, the hydroxyl groups in H3BO3 lead to the formation and release of acetylacetone at temperatures 
lower than 200 °C. As the ethoxy groups present in the polymer can react with metal acetylacetonates 
[193], no ethanol release can be observed during the thermal treatment of MK-Ca5, MK-Ca12 and MK-
B7Ca5. Instead, the acetylacetonate groups present in the precursors decompose upon acetone release 
at temperature beyond 200 °C.  
 
Figure 4-2. Schematic illustration of the chemical modification of the polymethylsilsesquioxane with boric 
acid and/or calcium acetylacetonate.  
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4.1.2. Structure characterization 
As shown in Figure 4-3, the FTIR spectra of the pyrolyzed silicon oxycarbides are dominated by absorp-
tions at about 460 cm-1, 1083 cm-1 and 1220 cm-1, corresponding to the deformation of O-Si-O bond and 
two asymmetric Si-O-Si stretching modes, respectively. The absorption at 800 cm-1 can be attributed to 
an overlapping of Si-C and bending Si-O-Si vibrations. Additionally, bands at 670 cm-1 and 912 cm-1 
corresponding to ν(Si-O-B) and at 1400 cm-1 assigned to ν(B-O) are observed in boron-containing sam-
ples, i.e. SiOC-B7Ca5 and SiOC-B7 [194-196]. The spectra of Ca-containing samples show several 
small absorption bands in the range from 940-1040 cm-1, indicating the existence of Si-O- sites (i.e., 
bearing non-bridging-oxygens) [197, 198]. Absorption bands at 564 cm.1 and 717 cm-1 were reported to 
be related to pseudowollastonite [199], and their intensities increase with increasing Ca content from 
SiOC-Ca5 to SiOC-Ca12 as shown in Figure 4-3. Based on the results from the FTIR spectroscopy, one 
can conclude that the incorporation of Ca and B within silicon oxycarbide occurs upon formation of 
silicon sites bearing non-bridging-oxygens (i.e., Si-O-), Si-O-B bonds and small amounts of pseudowol-
lastonite. 
 
Figure 4-3. FTIR spectra of silicon oxycarbide based samples prepared upon pyrolysis of the polyme-
thylsilsesquioxane based precursors at 1100 °C. 
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The pyrolyzed silicon oxycarbides were investigated furthermore by X-ray diffraction. Typically, the py-
rolysis of polysiloxanes, polysilsesquioxanes as well as of silicon-alkoxide-based sol-gel systems in inert 
gas atmosphere leads to the formation of amorphous silicon oxycarbides, as also shown in Figure 4-4 
for SiOC. The modification of MK with boron leads upon pyrolysis to a B-containing silicon oxycarbide, 
which keeps its amorphous nature, as already shown in many studies in literature [60, 200]. The incor-
poration of Ca into silicon oxycarbide, as for SiOC-Ca5, SiOC-Ca12 and SiOC-B7Ca5, leads also to 
mainly amorphous materials (see Figure 4-4). Some minor amounts of wollastonite and pseudowollas-
tonite were detected in the Ca-containing samples. The amount of crystalline phases correlates to the 
amount of incorporated Ca, i.e., the amount of wollastonite / pseudowollastonite in SiOC-Ca12 was 
higher than that in SiOC-Ca5. 
 
Figure 4-4. XRD pattern of silicon oxycarbide based samples prepared upon pyrolysis of the correspond-
ing precursors at 1100 °C. 
In Figure 4-5, bright field and high resolution TEM micrographs of SiOC-Ca5 and SiOC-B7Ca5 are 
shown. The samples are shown to be mainly amorphous, as indicated also by the XRD data, and contain 
small amounts of crystalline particles with sizes in the range from 200 to ca. 500 nm. EDS analysis was 
done by M.Sc. Maximilian Trapp and indicated in both samples in the two regions (i.e., amorphous and 
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crystalline) very different Ca contents. Thus, the amount of Ca in the amorphous regions of SiOC-Ca5 
and SiOC-B7Ca5 was shown to be in the range of 0.5-1 wt.%, whereas the crystalline regions exhibits 
a significantly higher Ca content of approximately 15-40 wt.%, being similar to the content of Ca in 
wollastonite / pseudowollastonite (23 wt.%). 
(a) 
 
(b) 
 
Figure 4-5. Bright field and high resolution TEM micrographs of the samples (a) SiOC-Ca5 and (b) SiOC-
B7Ca5. The FFT (Fast Fourier transformation) and SAED (selected area electron diffraction) insets de-
pict the amorphous or crystalline nature of the respective regions. As shown by the EDS measurements, 
the crystalline regions have a significantly higher Ca content than the Ca-poor amorphous parts, which 
is indicative for a phase separation process occurring in both samples. 
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Network architecture evaluation 
The effect of Ca incorporation into silicon oxycarbide has been studied by performing a network structure 
analysis via solid state NMR. 29Si NMR spectra measured for B and/or Ca modified silicon oxycarbides 
by Dr. Hergen Breitzke are shown in Figure 4-6. The spectra were deconvoluted into Gaussian/Lo-
rentzian peaks centered at -110, -91, -85, -72, -35, +6 and -11 ppm, which were assigned to Q4 (SiO4 
sites with 4 bridging-oxygens), Q3 (SiO4 sites with 3 bridging-oxygens and one non-bridging-oxygen), Q2 
(SiO4 sites with 2 bridging-oxygens and 2 non-bridging-oxygens), SiO3C, SiO2C2, SiOC3 and SiC4 sites, 
respectively [66]. The Q2 peak appears sharper and has a lower width than the other considered peaks, 
indicating that it does not belong to the oxycarbide amorphous network but rather corresponds to the 
calcium silicate crystalline phases (wollastonite / pseudowollastonite). Based on the fitted peak intensi-
ties, the fractions of different Si species were estimated and are summarized in Table 4-1. It can be 
concluded that the modification of silicon oxycarbide by B or Ca modification leads to a significant in-
crease of the Q4 site fractions at the expenses of the mixed-bonds sites such as SiO3C, SiO2C2, SiOC3 
and SiC4. Interestingly, when SiOC is modified with both B and Ca, the increase of the Q4 site fractions 
is only moderate.  
It has been shown in many studies that boron acts as a network former in silicon oxycarbides. Unlike B, 
Ca should be considered mainly as network modifier, i.e., being located at silicon sites containing non-
bridging oxygens. As the Q2 sites in the investigate samples have been assigned to wollastonite / 
pseudowollastonite, it is obvious that Ca is located at the Q3 sites detected in the Ca modified SiOC 
samples [65, 66]. 
SiOC-B7Ca5 and SiOC-Ca5 exhibit similar Ca/Si molar ratio and the fraction of Q3 units in SiOC-B7Ca5 
is slightly higher than that of SiOC-Ca5, indicating a better incorporation of Ca in amorphous silicon 
oxycarbide network in SiOC-B7Ca5. SiOC-Ca12 has significantly higher Ca/Si molar ratio, which is re-
flected in a higher Q2 site fraction, thus SiOC-Ca12 contains larger amount of wollastonite / pseudowol-
lastonite (as also shown in Figure 4-4). 
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Figure 4-6. 29Si MAS NMR spectra (top black lines) of (a) SiOC-B7, (b) SiOC-Ca5, (c) SiOC-B7Ca5 and 
(d) SiOC-Ca12. The spectra are fitted to Q4 SiO4 (peak I), Q3 SiO4 (peak II), SiO3C (peak III), SiO2C2 
(peak IV), SiOC3 (peak V), SiC4 (peak VI) and Q2 (wollastonite / pseudowollastonite) (peak VII) sites 
(bottom black lines). The sum of all fitted peaks yields the blue lines in the spectra. 
Table 4-1. Silicon site fractions in the prepared silicon oxycarbides determined from 29Si MAS NMR 
spectra. 
Sample Q4 (I) Q3 (II) SiO3C (III) SiO2C2 (IV) SiOC3 (V) SiC4 (VI) Q2 (VII)* 
SiOC [51] 44.0 - 30.4 16.1 3.0 6.5 - 
SiOC-B7 66.2 - 24.2 5.6 0.4 3.6 - 
SiOC-Ca5 54.3 3.5 18.6 12.9 1.4 8.4 0.9 
SiOC-B7Ca5 46.7 4.9 21.2 18.9 1.8 5.7 0.8 
SiOC-Ca12 55.3 6.0 16.5 10.4 0.2 7.7 3.9 
* The Q2 sites belong to the wollastonite / pseudowollastonite crystalline phases detected in SiOC-Ca5, SiOC-
B7Ca5 and SiOC-Ca12.  
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The 11B NMR spectra of SiOC-B7Ca5 and SiOC-B7 measured by Dr. Hergen Breitzke are shown in 
Figure 4-7. All spectra show quadrupolar splitting with a quadrupolar coupling constant CQ ≈ 2.6 MHz 
and an asymmetry parameter η ≈ 0.2, which were also reported elsewhere for boron-containing silicon 
oxycarbides [60]. The spectra can be deconvoluted to three signals centered at 12.5, 29 and 47 ppm, 
which were assigned to BO3, BO2C and BOC2  sites, respectively [201]. The BOxC3-x site fractions are 
summarized in Table 4-2. It is interesting to notice that the Ca modification of boron-containing silicon 
oxycarbide induces a decrease of the mix-bonded boron site fractions (see Table 4-2). 
 
 
Figure 4-7. 11B MAS NMR spectra (top black lines) of (a) SiOC-B7 and (b) SiOC-B7Ca5. The fitted 
signals are assigned to BO3 (I), BO2C (II) and BOC2 (III) sites (bottom black lines). The sum of all fitted 
signals yields the blue lines. 
Table 4-2. Boron site fractions in SiOC-B7 and SiOC-B7Ca5 determined from 11B MAS NMR spectra. 
Sample 
BO3 (I) 
CQ = 2.6 MHz 
η = 0.15 
BO2C (II) 
CQ = 2.6 MHz 
η = 0.2 
BOC2 (III) 
CQ = 2.6 MHz 
η = 0.2 
SiOC-B7 75 19 6 
SiOC-B7Ca5 88 9 3 
 
Chemical and phase compositions 
The pyrolyzed silicon oxycarbides were also investigated concerning their elemental composition. The 
results of the elemental analysis of the studied samples and the calculated empirical formulae are 
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summarized in Table 4-4. It is clearly shown that the Ca/Si molar ratios which were set in the precursors 
are kept upon pyrolysis, leading to the same values in the resulting silicon oxycarbides, whereas the 
B/Si molar ratios are slightly lower, which can be explained by some vaporization of B-containing species 
during the pyrolysis process [201, 202]. The chemical and phase compositions of the SiOC-based ma-
terials were estimated based on the elemental analysis data, as reported in [42, 54]. The fraction of the 
CaSiO3 crystalline phases in the investigated materials was estimated by evaluating the ratio Q2 (crys-
talline phase) : Q3 (amorphous matrix) from the NMR data (see Table 4-1). The estimated phase com-
positions are listed in Table 4-4. 
The chemical compositions show an increase of oxygen in the silicon oxycarbide network upon Ca 
and/or B modification. The carbon content in silicon oxycarbide seems not to be significantly affected 
upon Ca modification; while the incorporation of boron seems to “repel” carbon from the network. Inter-
estingly, also the content of the segregated sp2-hybridized carbon is affected by the modification of 
SiOC. Thus, incorporation of boron induces a decrease of the amount of free sp2 carbon in the samples, 
whereas the opposite trend is observed for Ca modification, where free carbon can be introduced during 
the pyrolysis of organic acetylacetonate group in Ca modifier (calcium acetylacetonate). 
In all Ca modified Si(B,Ca)OC systems, the fractions of the crystalline phase (i.e., wollastonite, 
pseudowollastonite) are relatively small. However, an increase of Ca modification from SiOC-Ca5 to 
SiOC-Ca12 leads to an increase of the content of wollastonite / pseudowollastonite, as shown in Table 
4-4, while the amounts of Ca incorporated in silicon oxycarbide amorphous matrix (i.e., Q3 fraction) are 
comparable. The phase diagram of the pseudo-binary SiO2-CaO system exhibits, similar to many other 
silica/alkaline-earth-metal-oxide systems, a miscibility gap in the range of Ca/Si ratio from 0.02 and 0.38 
[203, 204]. In this compositional range, the CaO-SiO2 melt partitions into two phases, i.e., one silica-rich 
and one calcium-rich component. The Ca/Si ratios in the silicon oxycarbide samples prepared in the 
present study range from 0.05 to 0.12 and thus lie also within the miscibility gap of the pseudo-binary 
SiO2-CaO system. Interestingly, the oxycarbide system seems to behave similarly to the SiO2-CaO sys-
tem, as also shown by the TEM results. 
Obviously, the SiOC-Ca5 and SiOC-Ca12 samples undergo a phase separation, leading to a Ca-poor 
silicon oxycarbide matrix and a calcium silicate (wollastonite / pseudowollastonite) crystalline phase. 
There are two interesting features of the silicon oxycarbide system which can be emphasized here: (i) 
the alkaline-earth-metal modified silicon oxycarbide network behaves similarly to the corresponding 
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silicate system – clearly, the incorporation of carbon into silica does not affect the typical miscibility gap 
feature of alkaline-earth-metal modified silicate glass networks; (ii) the effect of the carbon incorporation 
may correlate to the fact that the phase separation in the Ca-containing silicon oxycarbide network oc-
curs in the solid state, whereas the partitioning of SiO2/alkaline-earth-metal-oxide systems takes place 
in the molten state. 
The network connectivity of magnesium- and magnesium/calcium modified silicon oxycarbides has been 
calculated in order to compare the influence of network structure on their bioactivity [66]. Based on the 
solid-state NMR investigation from the present work, the network connectivity of the prepared samples 
can be calculated using equation (4-1), which considers the incorporated Ca as network modifier and 
boron as network former: 
 NC =[Si] x ([4 x f(Q4)] + [3 x f(Q3)] + [2 x f(Q2)] +[1 x f(Q1)] + [6 x f(SiO3C)] +[8 x 
f(SiO2C2)] + [10 x f(SiOC3)] + [12 x f(SiC4)])+[B] x ([3 x f(BO3)] +[5 x f(BO2C)] + [7 x 
f(BOC2)]) (4-1) 
with [Si] and [B] being the Si and B atomic fractions among total network formers and f(x) the site fraction 
of the corresponding species x from the experimental NMR data. The calculated network connectivity 
values are summarized in Table 4-3. 
Table 4-3. Network connectivity value NC calculated based on NMR data; the value of vitreous silica 
SiO2 is given for the sake of comparison. 
Sample SiO2 SiOC SiOC-B7 SiOC-Ca5 SiOC-B7Ca5 SiOC-Ca12 
NC 4.0 5.95 4.95 5.59 5.55 5.24 
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The carbon for oxygen substitution in silicate network leads to an extreme increase of the network con-
nectivity, as carbon is tetravalent and acts as a corner-linking “node” for four SiOxC4-x tetrahedra, 
whereas bridging oxygens link only two tetrahedra. Thus, the exchange of ca 13.5 at.% oxygen by car-
bon in the silicate network (which corresponds to the composition SiO1.47C0.27 in SiOC) leads to an in-
crease of the network connectivity from 4 (as for SiO2) to 5.95 [51, 66]. 
The incorporation of boron into the silicon oxycarbide network has been shown to repel carbon from the 
network, leading to a significant decrease in the network connectivity. Thus, the network connectivity of 
SiOC-B7 is 4.95. Also, the incorporation of Ca into the silicon oxycarbide network leads to a decrease 
of the network connectivity. Correspondingly, SiOC-Ca5 and SiOC-Ca12 show network connectivity val-
ues of 5.59 and 5.24, respectively. However, the decrease of the network connectivity upon Ca modifi-
cation is related to both the generation of Q3 sites (i.e., depolymerization of the network) and the de-
crease of the carbon content in the network. The increase of Ca amount reduces the network connec-
tivity value further though also increases the amount of crystalline secondary phase (wollastonite / 
pseudowollastonite) as shown by the increased fraction of Q2 sites. As discussed above, this effect 
relies on the partitioning of the Ca-containing silicon oxycarbide systems into a calcium-poor matrix and 
calcium-rich crystalline phase, similar to the behavior of SiO2-CaO systems lying in the compositional 
miscibility gap.  
The results presented here indicate that the network connectivity in silicon oxycarbides can be influ-
enced / finely tuned by using two different tools: (i) changing the carbon content of the network and (ii) 
introducing network depolymerization, similar to the silicate-based systems. It is expected that the two 
ways of modifying the network connectivity in amorphous silicon oxycarbides will have different effects 
on their bioactivity. Additionally, the in situ generation of highly bioactive / biodegradable phases (such 
as wollastonite or pseudowollastonite in the present study) embedded within a bioinert matrix (such as 
silicon oxycarbide) may be considered as a convenient preparative access to interesting phase compo-
sitions with tailored bioactivity. This concept was recently shown, e.g., for silica-bonded calcite prepared 
from CaCO3-filled silicones [205, 206]. 
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4.1.3. Ion release kinetics upon SBF exposure 
In vitro SBF assessment results of silicon oxycarbide based samples have been compared to that of the 
commercial Vitryxx® Bioactive Glass with 45S5 composition, i.e., with the chemical composition of 
Si1Na1.06Ca0.58P0.11O3.39 and a network connectivity value of 2.10 [89]. This glass sample will be denoted 
as 45S5 in the following work. 
As shown in Table 4-5, the mean particle sizes, d50, of the silicon oxycarbide based samples are com-
parable. N2 adsorptions isotherms (not shown here) are type II for both 45S5 and the prepared silicon 
oxycarbide based samples, indicating that they are non-porous or macroporous materials [207]. The 
BET SSA values and total pore volume calculated for the silicon oxycarbide based samples and 45S5 
were shown to be relatively low and comparable (see Table 4-5). As the SSA values are only 10-30 
m2/g, it is assumed that the influence of the SSA on the bioactivity behavior of these materials is negli-
gible. Consequently, differences in the bioactivity of the studied samples can be correlated exclusively 
to their chemical and phase composition as well as network architecture.  
Table 4-5. Mean particle size d50, BET specific surface area (SSA) analysis and total pore volume of 
silicon oxycarbide based samples and 45S5. 
Sample SiOC SiOC-B7 SiOC-B7Ca5 SiOC-Ca5 SiOC-Ca12 45S5 
d50 [μm] 10.0 16.0 20.3 16.5 27.9 6.5 
BET SSA [m2g-1] 19.9 26.7 15.6 10.1 21.0 18.9 
Total pore vol-
ume [cc/g] 
4.2x10-2 6.5x10-2 6.5x10-2 4.6x10-2 4.5x10-2 3.7x10-2 
 
The prepared silicon oxycarbide based samples were exposed to simulated body fluid (SBF) for different 
soaking time periods. Subsequently, the pH evolution of the SBF solutions with soaking time was as-
sessed. As it is observed in Figure 4-8 (a), the pH value of the SBF solutions increases with soaking 
time due to the ion exchange at the surface of the samples occurring between the protons in solutions 
and the cations (e.g., Ca2+) in the samples [208]. The soaking of SiOC does not change the pH value of 
the SBF solution noticeably, while the SBF solutions for the other investigated samples show pH in-
creases to different extents. The exposure of 45S5 to SBF leads to the highest pH value in the solution, 
i.e., higher than 8.0. Especially at the early stages of the SBF exposure of 45S5, the increase of the pH 
value is steep and has been associated with a cytotoxic effect of 45S5 within this time frame [209]. The 
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silicon oxycarbide samples modified with Ca and/or B lead to only slight increases of the pH values of 
the SBF solutions. As the SBF is a solution saturated with Ca and P [210], the pH increase in SBF 
solutions is expected to improve the precipitation of Ca, and thus the formation of calcium phosphate, 
resulting in an enhanced bioactivity [211]. Even if cytotoxicity studies were not conducted here, the fact 
that the pH of the medium does not change to critical values (in comparison to 45S5 glass) indicates 
that the silicon oxycarbide based samples investigated in the present study should not lead to cell death 
due to alkalization of the medium (as mentioned in section 2.2.1). Indeed, previous reports on Ca- and 
Mg-containing silicon oxycarbides have revealed their high compatibility with cells such as L-929, HEK-
293 or MEF [19, 21]. On the other hand, the bioactivity of the silicon oxycarbide based materials is 
expected to be lower than that of 45S5 glass. 
At the early stages of the SBF exposure, the Ca concentration in SBF solutions increases, as Ca is 
released from the samples (i.e., as for SiOC-B7Ca5, SiOC-Ca5, SiOC-Ca12, 45S5, see Figure 4-8 (c)). 
Interestingly, the Ca concentration in the SBF solution of the Ca-containing silicon oxycarbide samples 
decreases for longer soaking time, while it remains stable for 45S5. The P concentration in the SBF 
solutions decreases rapidly for all samples, reaching values lower than 5 mg/l for SiOC-B7Ca5, SiOC-
Ca5, SiOC-Ca12 and 45S5 after 1 week, as shown in Figure 4-8 (d). This has been attributed to the 
precipitation of calcium phosphate on the sample surface and thus correlates to its bioactivity. 
Arcos et al. [212] calculated the activation energy for Si release in melt and sol-gel derived silicate 
glasses and considered this as a parameter to evaluate their bioactivity. Correspondingly, it was shown 
that activation energies for Si release with values lower than 0.2 eV correlate to high bioactivity, whereas 
values larger than 0.5 eV are characteristic for non-bioactive silicate glasses. Intermediate values, i.e., 
between 0.35 and 0.5 eV, represent the boundary between bioactive and non-bioactive silicate-based 
glasses [212]. 
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Figure 4-8. Evolution of (a) pH value, (b) Si concentration, (c) Ca concentration, (d) P concentration of 
the filtered SBF solutions as a function of the soaking time for silicon oxycarbide based and 45S5 sam-
ples. (The ion concentrations of Si, Ca and P were measured by Dipl.-Geol. Christian Scholz) 
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In the present work, the activation energy for the Si release of silicon oxycarbide based and 45S5 sam-
ples was assessed upon considering the Si concentration in the SBF solution after 72h exposure to the 
simulated body fluid at three temperatures, i.e., 24, 37 and 55 °C. The Arrhenius plot of the data accord-
ing to equation (4-2): 
 𝑙𝑛([𝑆𝑖]) = 𝐶 − 𝐸𝑎/𝑅𝑇 (4-2) 
where [Si] is the concentration of Si in the SBF solution, C is a constant, R the universal constant of gas 
and T the absolute temperature, is shown in Figure 4-9. 
 
Figure 4-9. Arrhenius plots of silicon release after 3 days SBF testing at 24 °C, 37 °C and 55 °C for the 
investigated samples. 
In Figure 4-9, there are two groups among the assessed samples: firstly, SiOC and SiOC-B7 show 
relatively large activation energies for Si release, i.e., 0.27 and 0.32 eV, respectively; whereas 45S5 and 
SiOC-Ca5/SiOC-Ca12 exhibit significantly lower values for Ea, i.e., 0.04 and 0.07 eV, respectively. Sam-
ple SiOC-B7Ca5 shows with 0.16 eV an intermediate value for the activation energy. The incorporation 
of boron into the silicon oxycarbide network is shown to not affect significantly the activation energy for 
Si release; whereas the Ca modified materials SiOC-Ca5 and SiOC-Ca12 have Ea values which are 
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similar to that of 45S5. Consequently, it may be expected that SiOC-Ca5 and SiOC-Ca12 exhibit high 
bioactivity (at least higher than that of SiOC and SiOC-B7). This correlates to the Si and Ca release 
kinetics of the samples (see Figure 4-8). 
4.1.4. Biomineralization upon SBF exposure 
The formation of surface charges when the silicon oxycarbide based samples as well as 45S5 glass 
(before and after 4 h and 8 h SBF test) are dispersed in water (pH ≈ 5.0) was estimated by determining 
their zeta potential. As shown in Figure 4-10 (a), all silicon oxycarbide based samples and 45S5 have 
negative surface charges, resulting from the dissociation of surface silanol groups (Si-OH) to Si-O- at 
pH values higher than the isoelectric point of silica, which is pH = 1.6 as reported by Fisher et al [213, 
214]. Since SiOC has Si-O, Si-C and C-C bonds, the surface charge of SiOC can be estimated by the 
surface charges of silica, SiC and graphite, which have zeta potential values of ca. -40 mV, -25 to -40 
mV and –45 mV at pH = 5.0, respectively [214-216]. Correspondingly, the zeta potential of SiOC before 
SBF test was measured to be ca. -38 mV (see Figure 4-10 (a)). Interestingly, 45S5 has zeta potential 
of -39 mV, close to -40 mV of silica at pH = 5.0, despite of its high content of Ca2+ and Na+, which could 
be correlated to the fast formation of silica-based hydrated surface layer during the measurement [217]. 
In contrary, the as-prepared Ca/B modified silicon oxycarbides have zeta potential values between -28 
and -36 mV, showing a positive shift compared to that of SiOC. Ca-containing species such as calcium 
silicate hydrate have zeta potential values that are less negative than that of silica, and boron carbide 
with B-C bonds that also exist in B modified silicon oxycarbide, shows positive zeta potential at pH = 
5.0, indicating the positive shift to be related to the incorporated Ca and B on particle surfaces [218, 
219].  
After 4 h and 8 h SBF test, the change of surface charge, i.e., zeta potential, of 45S5 and silicon oxycar-
bide based samples showed different tendencies. In Figure 4-10 (a), three different groups can be dis-
tinguished: (i) SiOC-Ca12 and 45S5, showing a decrease in their absolute zeta potential value and 
reaching a value similar to that of reference synthetic hydroxyapatite powder upon 8 h SBF exposure, 
(ii) SiOC-B7, SiOC-B7Ca5 and SiOC-Ca5 with an increase of their absolute zeta potential value, and 
(iii) SiOC with practically no or little change in the zeta potential. The shifting of zeta potential towards 
that of hydroxyapatite implies that the formation of calcium phosphate-like substance may have hap-
pened on SiOC-Ca12 and 45S5 surface after 8 h test. The shift of zeta potential towards negative value 
for SiOC-B7, SiOC-B7Ca5 and SiOC-Ca5 suggests the leaching of surface B and Ca ions and the 
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formation of hydrated silica surface layer, which is beneficial for the nucleation of hydroxyapatite during 
the SBF exposure, since the more negative the surface of the glass samples, the stronger its tendency 
to attract Ca2+ cations. 
Therefore, the evolution of zeta potential with soaking time can be illustrated in Figure 4-10 (b): 45S5 
and silicon oxycarbide based samples all experienced a surface activation process, which was followed 
by the precipitation of hydroxyapatite on the surface. However, the surface activation on 45S5 and SiOC-
Ca12 were very fast, so that zeta potential shifted positively due to hydroxyapatite precipitation already 
after 4 h, while the hydrated silica layer was still forming on the surfaces of SiOC-B7, SiOC-Ca5 and 
SiOC-B7Ca5 after 8 h, leading to a negative zeta potential shift. Thus, all investigated samples may 
exhibit the same behavior concerning their surface evolution when exposed to SBF conditions, i.e., firstly 
generating a silica gel layer upon leaching of species into SBF, followed by hydroxyapatite precipitation. 
This evolution can be rationalized by considering the evolution of the zeta potential of the samples which 
in the first step goes towards the value of silica gel (ca. -40 mV) and then increases towards the value 
of HA (ca. -21 mV). The difference between the investigated samples relies on the time scale in which 
the materials go through the mentioned stages: 45S5 and SiOC-Ca12 show very fast formation of silica 
gel and HA, and consequently their zeta potential measured after 4 and 8 h of SBF test reflects the 
formation of hydroxyapatite on their surface. Unlike 45S5, the measurements of the zeta potential after 
4 and 8 h SBF test indicate that SiOC-B7, SiOC-B7Ca5 and SiOC-Ca5 are still within the stage of silica 
gel formation (and thus no HA precipitation on the surface yet occurred). Finally, SiOC is found to be 
the most sluggish sample, with the surface being not significantly altered within the first 8 h of SBF 
exposure. However, it is expected that SiOC would show same behavior like that of the Ca modified 
samples, i.e., silica gel formation and HA precipitation, though in a significantly larger time frame. This 
is in agreement with observations made in literature, which showed the silicon oxycarbide materials with 
similar chemical compositions were exhibiting HA mineralization upon 5 weeks of SBF exposure [20]. 
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Figure 4-10. (a) Evolution of surface charge during the first 8 h of the SBF test, measured on zeta 
potential of particles in deionized water (pH ≈ 5.0), for SiOC, SiOC-B7, SiOC-B7Ca5, SiOC-Ca5, SiOC-
Ca12 and 45S5; (b) Schematic illustration of zeta potential evolution with soaking time during the SBF 
test for 45S5, Si(Ca,B)OC and SiOC. Shadowed region refers to the first 8 h of soaking, during which 
the zeta potential was measured in the present study. It is seen, that the samples are assumed to show 
the same evolution concerning their zeta potential, i.e., approaching in a first step the zeta potential 
value of silica (gel) and subsequently evolving towards the value of HA. The difference between the 
samples relies only (and mainly) on the different time needed to develop the HA precipitates on their 
surface. 
(b) 
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The samples exposed to SBF for 4 weeks were characterized by means of X-ray diffraction (see Figure 
4-11 (b)). The XRD patterns indicate that all soaked samples are X-ray amorphous, exhibiting a low 
intensity reflection at a 2-theta value of ca. 14.5°, which was assigned to the (211) reflection of hydrox-
yapatite (HA) and carbonated hydroxyapatite (HCA) [220, 221]. Interestingly, a comparison with XRD 
patterns of the samples before SBF soaking (see Figure 4-11 (a)) shows that the small amounts of 
wollastonite / pseudowollastonite secondary phases present in some samples (e.g., SiOC-Ca5) have 
disappeared after SBF soaking. The vanishment of wollastonite / pseudowollastonite from the XRD pat-
terns of the samples could be confirmed as early as 3 days of SBF soaking (XRD patterns not shown 
here). Most probably, the release kinetics of these phases, which consist mainly of Q2 sites, is relatively 
fast during the SBF test. The question, whether and to which extent the presence and fast dissolution 
of wollastonite / pseudowollastonite influence the bioactivity of the investigated Si(B,Ca)OC samples, 
will be critically considered in the present study. 
FTIR spectra in Figure 4-12 (a) for samples before SBF soaking show Si-O-Si vibrations at 470, 1083 
and 1220 cm-1 for silicon oxycarbides, and at 500 cm-1 and 1035 cm-1 for 45S5. The shifting of Si-O-Si 
absorption in 45S5 is related to Na+ and Ca2+ presence in glass network. And a strong absorption of Si-
ONBO (non-bridging-oxygen) can be observed in 45S5 [222, 223]. Additionally, B-O vibration at 1415 cm-
1 can be observed for the B modified silicon oxycarbides SiOC-B7, SiOC-B7Ca5 [196].  
After 4 weeks SBF test, absorption bands of tetrahedral PO43- groups at 605, 565 and 1030 cm-1 can be 
identified in Figure 4-12 (b), which demonstrates calcium phosphate mineralization [89]. These absorp-
tion bands are most significant for 45S5, followed by SiOC-Ca12. The other silicon oxycarbide samples, 
i.e., SiOC, SiOC-Ca5, SiOC-B7Ca5 and SiOC-B7, show similar FTIR spectra after 4 weeks of SBF test, 
in which the existence of PO43- is verified mainly by the absorption band at 1030 cm-1. It is also interesting 
to notice that after 4 weeks of SBF exposure, CO32- vibrations at 875, 1420 and 1460 cm-1 can be 
observed for 45S5 [224], though not for the silicon oxycarbide based samples. Thus, calcium phosphate 
precipitation on 45S5 can be assigned to carbonated hydroxyapatite (HCA); whereas the precipitation 
on all silicon oxycarbide based samples seems to be rather hydroxyapatite (HA). This difference can be 
explained by the much higher pH increase during the SBF exposure of 45S5 as compared to that of 
silicon oxycarbides, since high pH value favors the carbonate precipitation [225]. 
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Figure 4-11. XRD diffractograms of silicon oxycarbide based and 45S5 samples (a) before SBF soaking 
and (b) after 4 weeks soaking in SBF. 
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A comparison between the FTIR spectra of SiOC-B7 and SiOC-B7Ca5 before and after SBF exposure 
(see Figure 4-12) reveals furthermore that the absorption band for B-O vibration is significantly weak-
ened after the SBF test, indicating the release of B into the SBF solution. However, the investigation of 
the possible angiogenesis effect of such B release, as mentioned in 2.2.2, is not included in the present 
study. 
The observation from XRD and FTIR analysis proves the formation of (carbonated) hydroxyapatite 
(HCA/HA) on all investigated systems after 4 weeks SBF test, and this formation is responsible for the 
decrease of P and Ca concentrations during SBF tests as shown in Figure 4-8. Therefore, the prepared 
silicon oxycarbide systems are considered to be bioactive. However, the observed XRD and FTIR sig-
nals for HA or HCA on silicon oxycarbide samples are significantly lower than that of 45S5 and other 
silicate based bioactive glasses [222, 226]. This is related to the limited amount of phosphate available 
for the investigated silicon oxycarbides, as shown by the rapid decrease of P concentration in the SBF 
solution (see Figure 4-8 (d)); while 45S5 contains itself phosphate, in addition to that provided by the 
SBF solution. Under static SBF test condition, which means that SBF solution is not circulated with an 
external reservoir to keep Ca and P concentration stable [210], the phosphate deposition on the inves-
tigated silicon oxycarbides is limited, while the P release from 45S5 can continuously support this pro-
cess. Therefore, XRD and FTIR techniques may not be sensitive enough to reveal the onset of the 
hydroxyapatite deposition on the surface of the silicon oxycarbide based samples. 
The hydroxyapatite formation on the surface of the studied silicon oxycarbide based samples was also 
assessed by using scanning electron microscopy (SEM). As shown in Figure 4-13, the precipitation of 
HA on 45S5 can be observed after one day, which is in good agreement with results reported in literature 
[89], while the biomineralization process on SiOC needs significantly longer time, i.e., ca. 4 weeks. The 
modification of the silicon oxycarbide network with boron (as for SiOC-B7) leads to a decrease of the 
HA formation onset time from 4 weeks to 3 weeks; whereas, the incorporation of Ca is shown to signif-
icantly accelerate the HA mineralization. Correspondingly, HA was detected by SEM on SiOC-Ca5 and 
SiOC-Ca12 after one week and three days of SBF exposure, respectively (see Figure 4-13), in agree-
ment with the ion release kinetics shown in Figure 4-8.  
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Figure 4-12. FTIR spectra of silicon oxycarbide based and 45S5 samples (a) before SBF soaking and 
(b) after 4 weeks soaking in SBF. 
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Figure 4-13. SEM micrographs obtained at the earliest time points of the individual samples to visually 
detect hydroxyapatite formation after SBF exposure.  
(a) 45S5 after 1 day SBF test   
TRsettesttesttestest 
1 um 
(b) SiOC after 4 weeks SBF test   
TRsettesttesttestest 
(c) SiOC-B7 after 3 weeks SBF test   
TRsettesttesttestest 
(d) SiOC-B7Ca5 after 1 week SBF test   
TRsettesttesttestest 
(e) SiOC-Ca5 after 1 week SBF test   (f) SiOC-Ca12 after 3 days SBF test   
TRsettesttesttestest 
1 um 
1 um 1 um 
1 um 1 um 
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4.1.5. Structure-bioactivity correlation 
It is obvious that the network connectivity of all silicon oxycarbide based samples is significantly higher 
than that of 45S5 glass, due to the incorporation of sp3 bonded carbon in the glass network, as men-
tioned above. Moreover, various Raman spectroscopic studies have confirmed carbon D and G vibration 
modes in polymer derived silicon oxycarbides, and these vibrations are correlated to sp2 bonded carbon 
with defects [40, 52]. The fractions of this so-called “free” sp2 carbon in silicon oxycarbide based samples 
in the present study have been estimated in Table 4-4. Since carbon materials are bioinert [227], the 
influence of the “free” carbon content in silicon oxycarbide based samples on bioactivity behavior will 
not be considered in the present study.   
The prepared silicon oxycarbide based samples (SiOC and Si(B,Ca)OC) were found to be mainly X-ray 
amorphous, as shown in Figure 4-4. Only small amounts of wollastonite and/or pseudowollastonite were 
detected in the Ca-containing samples, mainly in SiOC-Ca12. It can be seen in Table 4-4, that the 
amount of secondary silicate phase (wollastonite / pseudowollastonite) in the prepared samples is rela-
tively low. For instance, the molar ratio Siwollastonite/pseudowollastonite : Sisilicon oxycarbide glass in SiOC-Ca5 and 
SiOC-Ca12 was 1.73 : 100 and 7.30 : 100, respectively. 
The in vitro bioactivity assessment results showed that ternary silicon oxycarbide (SiOC) is a bioactive 
material. Ca incorporation increases the bioactivity of SiOC significantly, as shown for SiOC-B7Ca5, 
SiOC-Ca5 and SiOC-Ca12. This Ca effect on bioactivity is related to the unique microstructure and 
phase compositions of the Ca modified silicon oxycarbides. The incorporation of Ca in silicon oxycarbide 
reduces the network connectivity of the silicon oxycarbide network on the one hand (see Table 4-3), and 
leads to the formation of small amounts of calcium silicate (pseudowollastonite / wollastonite) on the 
other hand. 
In order to separate these two effects, SiOC-B7Ca5 and SiOC-Ca5/SiOC-Ca12 are compared. SiOC-
B7Ca5 has a higher Si release activation energy (i.e., 0.16 eV) than that of SiOC-Ca5/SiOC-Ca12 (i.e., 
0.07 eV, see Figure 4-9); however, the amount of released Si in the case of SiOC-B7Ca5 is higher than 
that of SiOC-Ca5 (see Figure 4-8 (b)). This inconsistency reveals different contributions of two possible 
release paths for Si in SiOC-B7Ca5, either from the secondary calcium silicate phase (wollastonite / 
pseudowollastonite) or from the amorphous silicon oxycarbide network. Since the activation energy for 
silicon release of SiOC-Ca5/SiOC-Ca12 (0.07 eV) is similar to that of calcium silicate (0.09 eV, as for α- 
and β-calcium silicate in Tris buffer solution [14]), the Si release in SiOC-Ca5/SiOC-Ca12 is shown to 
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be dictated by the crystalline calcium silicate phase; while in the case of SiOC-B7Ca5 the Si release is 
mainly determined by the silicon oxycarbide glass network. Therefore, crystalline calcium silicate phase 
has stronger influence on bioactivity for SiOC-Ca5/SiOC-Ca12, i.e., silicon oxycarbide with only Ca 
modification, than for SiOC-B7Ca5, i.e., silicon oxycarbide with both Ca and B modification. 
Table 4-6. Average Si release rates (values normalized to Si content in amorphous silicon oxycarbide 
network) between 3 days and 4 weeks soaking time. 
Sample SiOC SiOC-B7 SiOC-B7Ca5 SiOC-Ca5 SiOC-Ca12 
Si average release rate (%/h) 0.0013 0.0022 0.0047 0.0015 0.0017 
 
Meanwhile, the Si release for Ca modified Si(B,Ca)OC samples in Figure 4-8 (b) shows a strong in-
crease in the first 3 soaking days, but slows down and has a linear-like behavior from 3 days to 4 weeks. 
Due to the fact that crystalline calcium silicate was not detectable anymore after 3 days of SBF soaking, 
the rapid increase of the Si concentration in the SBF solution at the beginning of the SBF test is related 
to the dissolution of crystalline calcium silicate phase, and is corroborated by the low Si release activa-
tion energies for SiOC-Ca5/SiOC-Ca12. The average Si release rates from silicon oxycarbide network 
between 3 days and 4 weeks can be compared by normalizing the released Si amounts in this time 
period to the total Si amounts in the amorphous network, which were calculated from the chemical and 
phase compositions in Table 4-4. The results are summarized in Table 4-6.  
The average Si release rates show a clear correlation with the calculated network connectivity values 
(see Table 4-3). With decreased network connectivity, higher Si release rate from the amorphous net-
work could be achieved. The decrease of network connectivity in silicon oxycarbide results from both 
the depolymerization of the network via Ca incorporation at non-bridging-oxygen sites and the removal 
of network carbon. Consequently, SiOC-Ca5/SiOC-Ca12 with depolymerized silicon oxycarbide network 
has higher Si release rate than SiOC; SiOC-B7 has less network carbon than SiOC, also resulting in 
higher Si release (see Table 4-6). However, it is interesting to observe, that although SiOC-B7Ca5 has 
higher network connectivity than that of SiOC-B7 (5.55 compared to 4.95), its Si release rate is two 
times higher than that of SiOC-B7. As shown in Table 4-4, SiOC-B7Ca5 has incorporated Ca in silicon 
oxycarbide network, forming non-bridging-oxygens, while SiOC-B7 has reduced network carbon com-
pared to SiOC. From equation (4-1), it is to know, that the removal of network carbon has stronger effect 
on reducing network connectivity than network depolymerization via non-bridging-oxygens. 
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Nevertheless, the network Si release implies a stronger influence from the depolymerized network, 
namely the network depolymerization improves the Si release and thus the bioactivity significantly. 
Therefore, in Si(B,Ca)OC silicon oxycarbide systems, both minor calcium silicate secondary phase (wol-
lastonite / pseudowollastonite) and network connectivity decrease in silicon oxycarbide amorphous ma-
trix have contributions to the improvement of apatite forming ability upon SBF exposure of Si(B,Ca)OC 
compared to SiOC. While crystalline phases determine the early soaking stages (up to 3 days) during 
SBF test, the decrease of network connectivity improves Si release and thus bioactivity continuously. 
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4.2. PMS derived Si(B,Ca,Sr)OC bioactive materials 
The study on Si(B,Ca)OC materials indicates the influence of B on enhancing the incorporation of Ca 
into amorphous SiOC network and the formation of Q3 units, as shown by the high Si release of SiOC-
B7Ca5 sample from amorphous network after 3 days soaking (see Figure 4-8). It is well known, that the 
release of Sr from bioactive materials may heal osteoporosis (as mentioned in section 2.2.2). Therefore, 
two Sr modified SiOC-B7Ca5 samples, i.e., SiOC-B7Ca5Sr0.8 and SiOC-B7Ca5Sr4 with Sr/Si molar 
ratio of 0.008 and 0.04 respectively, were prepared in the same way from PMS based precursors ac-
cording to Table 3-1. In the following sections, the influence of strontium modification on the ion release 
and apatite forming ability of Si(B,Ca,Sr)OC materials upon SBF immersion is discussed and compared 
with the behavior of SiOC-B7Ca5. 
4.2.1. Structure characterization 
 
Figure 4-14. XRD patterns of Si(B,Ca,Sr)OC samples and SiOC-B7Ca5. 
As shown in Figure 4-14, even at a very low Sr loading (Sr/Si = 0.008), SiOC-B7Ca5Sr0.8 has much 
stronger crystallization than SiOC-B7Ca5. As mentioned in section 2.1.2, the crystallization of SiO2 in 
ternary silicon oxycarbide is suppressed by “free carbon” and nano-domain structure that prevent nuclei 
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growth. However, both SiOC-B7Ca5Sr0.8 and SiOC-B7Ca5Sr4 have high amounts of cristobalite and 
quartz. The incorporation of network modifiers into silicate glasses has been reported to increase the 
SiO4 tetrahedron mobility and thus its crystallization tendency [228]. SiOC-B7Ca5Sr0.8 and SiOC-
B7Ca5Sr4 have high fractions of network modifiers (both Sr and Ca). Since Sr2+ is slightly larger than 
Ca2+, the network loosening and thus pro-crystallization effect of Sr is stronger than that of Ca; at a 
Ca/Sr molar ratio of 4/5 (close to 1) in the case of SiOC-B7Ca5Sr4, metasilicate eutectic systems can 
form, which favors the crystallization [229]. Both factors may have promoted the crystallization of SiO2 
in SiOC-B7Ca5Sr0.8 and SiOC-B7Ca5Sr4. Furthermore, Sr has a strong tendency to form strontium 
silicate phases in silicon oxycarbide systems, i.e., SrSiO3 at Sr/Si = 0.008 and additionally Sr2SiO3 at 
Sr/Si = 0.04. Thus, Si(B,Ca,Sr)OC samples show complex crystalline structure (i.e., cristobalite, quartz, 
strontium silicates, calcium silicate). 
4.2.2. Ion release kinetics upon SBF exposure 
The BET specific surface area values, calculated for SiOC-B7Ca5Sr0.8 and SiOC-B7Ca5Sr4, are com-
parable to that of SiOC-B7Ca5 (see Table 4-7). Therefore, in the following comparison of their ion re-
lease kinetics and biomineralization upon SBF immersion, the influence of specific surface area will be 
considered as negligible. 
Table 4-7. BET specific surface area (SSA) analysis and total pore volume of Si(B,Ca,Sr)OC samples, 
with comparison to that of SiOC-B7Ca5. 
Sample SiOC-B7Ca5 SiOC-B7Ca5Sr0.8 SiOC-B7Ca5Sr4 
BET SSA [m2g-1] 15.6 23.5 20.2 
Total pore volume 
[cc/g] 
6.5x10-2 7.4x10-2 5.9x10-2 
 
The pH evolutions with soaking time upon SBF immersion for SiOC-B7Ca5Sr0.8 and SiOC-B7Ca5Sr4 
were compared with that of SiOC-B7Ca5 in Figure 4-15. Additional Sr incorporation has increased the 
pH value in test fluids slightly compared to SiOC-B7Ca5. The ion exchange of network modifier cations 
Ca and Sr with protons in SBF solution is responsible for such pH increase according to Hench [2]. 
Thus, SiOC-B7Ca5Sr4 with the highest content of network modifier has the highest pH increase among 
the investigated samples (see Figure 4-15). It is also worthy to mention, that even in the case of SiOC-
B7Ca5Sr4, the highest pH value (ca. 7.6) is still significantly lower than that (ca. 8.2) induced by the 
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bioactive glass with 45S5 composition (see Figure 4-8). Thus, pH increase related cytotoxic effects are 
expected to be absent for the investigated materials. However, high pH value is beneficial for calcium 
phosphate precipitation [211]. SiOC-B7Ca5Sr0.8 and SiOC-B7Ca5Sr4 are thus expected to have higher 
apatite forming ability than SiOC-B7Ca5. 
 
Figure 4-15. Evolution of pH value of the filtered SBF solutions as a function of the soaking time for 
Si(B,Ca,Sr)OC samples and SiOC-B7Ca5. 
SiOC-B7Ca5Sr0.8 and SiOC-B7Ca5Sr4 show fast Si release within the first 3 days, similar to that of 
SiOC-B7Ca5 (see Figure 4-16 (a)). XRD investigation on Si(B,Ca,Sr)OC samples after 3 days SBF test 
confirms a complete dissolution of calcium silicate and strontium silicate phases (see Figure 4-17 (a)). 
Therefore, the fast initial Si release is rather related to the dissolution of silicate phases. A similar be-
havior was observed for Sr release. Interestingly, the ratio of Sr concentration in SBF solutions between 
SiOC-B7Ca5Sr0.8 and SiOC-B7Ca5Sr4 after 3 days is ca. 1:5, corresponding to the ratio of their Sr 
content (0.008:0.04). Thus, the released amount of Sr is proportional to the initial content of Sr in the 
material, implying a controllable Sr release by adjusting the material composition. However, Sr concen-
tration is rather stable after the initial bursting. Thus, Sr in material was either depleted after 3 days or 
certain equilibrium between Sr release and consumption was reached. 
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Figure 4-16. Evolution of (a) Si concentration, (b) Ca concentration, (c) P concentration and (d) Sr con-
centration of the filtered SBF solutions as a function of the soaking time for Si(B,Ca,Sr)OC samples and 
SiOC-B7Ca5. (The ion concentrations of Si, Ca, P and Sr were measured by Dipl.-Geol. Christian 
Scholz) 
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Higher pH increase in case of SiOC-B7Ca5Sr4 implies higher calcium phosphate precipitation. How-
ever, the evolutions of Ca and P concentration with soaking time (see Figure 4-16 (b) and (c)) show a 
slightly delayed consumption of Ca and P for SiOC-B7Ca5Sr4. The reason may lie in the reached high 
Sr concentration (ca. 50 mg/L) in SBF solution for SiOC-B7Ca5Sr4, which can inhibit calcium phosphate 
deposition, as reported by Koutsoukos et al [230]. Furthermore, a simultaneous decrease of Sr, Ca and 
P concentrations after 3 days was observed. The consumption of Sr is probably related to the formation 
of Sr substituted hydroxyapatite [231, 232]. Moreover, SiOC-B7Ca5 and SiOC-B7Ca5Sr0.8 show cer-
tain redissolution of precipitated calcium phosphate or hydroxyapatite, as being indicated by the slight 
increase of Ca and P concentrations after 2 weeks (see Figure 4-16 (b) and (c)). Such redissolution 
behavior is absent for SiOC-B7Ca5Sr4, implying that the Sr presence in solution suppresses hydroxy-
apatite redissolution, as also reported elsewhere [233]. 
4.2.3. Biomineralization upon SBF exposure 
Although the formation of hydroxyapatite is not obvious in XRD analysis (see Figure 4-17 (a)), SEM 
surface analysis shows hydroxyapatite-like morphology on SiOC-B7Ca5Sr0.8 and SiOC-B7Ca5Sr4 al-
ready after 3 days SBF soaking (see Figure 4-18 (b) and (e)) [234, 235]. For SiOC-B7Ca5, the hydrox-
yapatite formation can be observed only after 7 days soaking (see Figure 4-13 (d)), although the faster 
decrease of Ca and P in SBF solution indicates faster calcium phosphate formation on SiOC-B7Ca5 
than on SiOC-B7Ca5Sr4. This discrepancy can be explained by a retarded transformation of amorphous 
calcium phosphate into hydroxyapatite due to the lower pH increase upon SBF immersion of SiOC-
B7Ca5 (see Figure 4-15 and Figure 4-16 (b)) [236]. Furthermore, the precipitation after 3 days on SiOC-
B7Ca5Sr4 shows less defined hydroxyapatite-like shape than that on SiOC-B7Ca5Sr0.8 (see Figure 
4-18). This is in good agreement with the observation of the faster Ca and P consumption for SiOC-
B7Ca5Sr0.8. Moreover, a small diffraction peak, corresponding to hydroxyapatite, can be observed for 
Sr-containing samples after 7 days soaking, while this peak is almost negligible for SiOC-B7Ca5 (see 
Figure 4-17 (b)). 
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Figure 4-17. XRD patterns of Si(B,Ca,Sr)OC samples and SiOC-B7Ca5 (a) after 3 days SBF soaking 
and (b) after 7 days SBF soaking. 
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Therefore, Sr addition into Ca and B modified silicon oxycarbide has certain influences on their hydrox-
yapatite forming ability. However, this effect is more obvious for low Sr loading (Sr/Si = 0.008) than for 
high Sr loading (Sr/Si = 0.04). At the same time, Sr incorporation induces strong devitrification in silicon 
oxycarbide. Thus, the mechanism behind such bioactivity adjustment is complex. Both the formation of 
dissolvable strontium silicate phases and the formation of quartz and cristobalite phases may be re-
sponsible for the increased Si release, and thus improved bioactivity. Additionally, Sr presence in SBF 
solutions seems to result in the formation of Sr-substituted hydroxyapatite and suppress the hydroxyap-
atite redissolution. Thus, the influence of released Sr in SBF solutions on apatite formation should also 
be taken into consideration. 
On the other hand, Sr release from Sr-containing samples is very fast and correlated directly to its initial 
content in test materials. In the present study, the Sr concentration in SBF solution reaches 10-50 mg/L 
after only 3 days, which may be beneficial for achieving osteoporosis-healing effects [120, 229]. How-
ever, a more controllable, i.e., slower and continuous, Sr release was absent, which is probably related 
to the strong presence of Sr in crystalline strontium silicate and the suppressed incorporation of Sr into 
silicon oxycarbide amorphous matrix. Thus, silicon oxycarbide systems with a high capacity to incorpo-
rate Sr in amorphous matrix should be investigated in the future. 
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Figure 4-18. SEM surface morphology of SiOC-B7Ca5Sr0.8 and SiOC-B7Ca5Sr4 after 1 day, 3 days 
and 7 days SBF soaking.  
SiOC-B7Ca5Sr0.8 - 1 day SBF soaking 
SiOC-B7Ca5Sr0.8 - 3 days SBF soaking 
 
SiOC-B7Ca5Sr0.8 - 7 days SBF soaking 
 
SiOC-B7Ca5Sr4 - 1 day SBF soaking 
 
SiOC-B7Ca5Sr4 - 3 days SBF soaking 
 
SiOC-B7Ca5Sr4 - 7 days SBF soaking 
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4.3. Sol-gel derived Si(Ca)OC bioactive materials 
High specific surface area is beneficial for achieving high bioactivity in the case of bioactive silicate 
glasses (see section 2.2.1) and is related to mesoporous structure of the materials. Moreover, mesopo-
rosity can provide some added medical functions, such as the delivery of growth factors or antibiotics 
(see section 2.3.3). Mesoporous bioactive silicon oxycarbide materials can thus be promising candi-
dates for potential bone tissue engineering applications. 
Mesoporous silicon oxycarbide have been achieved by applying sol-gel synthesized precursors [176, 
237], using mesoporous templates [238] or applying post-synthesis treatments of HF etching or air cal-
cination [239]. Particularly, the versatility of the sol-gel approach is beneficial for preparing SiOC with 
tunable porosity, and the achieved porous SiOC materials have been reported to possess high specific 
surface areas (i.e., > 500 m2/g) [237, 240, 241]. However, typical sol-gel process for metal modified 
silicon oxycarbides is realized via co-polymerization between alkoxysilanes and metal alkoxides [242, 
243] and organic metal alkoxides are costly and also difficult to handle due to their high tendency to 
hydrolyze with moisture in air [104]. Furthermore, the use of metal alkoxides requires the usage of (pos-
sibly toxic) organic solvents, which is not recommendable from environmental aspects. A clean (water-
based) process to prepare metal-containing silicon oxycarbide is necessary, as it has been used for the 
synthesis of silicate based bioactive glasses [204, 244]. In following sections, the feasibility of inorganic 
metal source (calcium nitrate) for modifying silicon oxycarbides and its influence on the material porosity 
will be investigated. 
For this purpose, Ca-containing silicon oxycarbides (Si(Ca)OC) were thermally converted from xerogels 
derived from sol-gel synthesis of triethoxymethylsilane and calcium nitrate in inert gas atmosphere. The 
porous structure and specific surface area of prepared silicon oxycarbide samples were analyzed with 
N2 sorption method, accompanied with SEM surface morphology analysis. A correlation between the 
final porosity of silicon oxycarbide samples and the influence of calcium nitrate loading will be discussed. 
Furthermore, in vitro SBF bioactivity assessment has been conducted, in order to investigate the effects 
of Ca loading and porosity on bioactive behavior. 
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4.3.1. Structure characterization 
The xerogels prepared according to Figure 3-2 were investigated by means of FTIR spectroscopy. As 
evident from Figure 4-19 (a), the spectra of all prepared xerogels exhibit O-Si-O, Si-C, Si-O-Si, Si-CH3 
vibrations [17, 196, 245]. Moreover, the Ca-containing xerogels, SG-Ca5, SG-Ca12 and SG-Ca50, show 
the presence of NO3- vibration (ca. 1380 cm-1) and OH/H2O vibration (ca. 1630 cm-1) indicating the 
presence of residual nitrate and hydroxy groups after drying [204, 244]. The peak intensity ratio of v(NO3-
)/v(Si-O-Si) is shown to increase from SG-Ca5 to SG-Ca50, correlating to the increasing calcium nitrate 
loading from SG-Ca5 to SG-Ca50. The XRD patterns of the prepared xerogels (see Figure 4-19 (b)) 
indicate that SG-Ca0, SG-Ca5 and SG-Ca12 are X-ray amorphous; whereas, crystalline calcium nitrate 
(hydrate) phases were observed in SG-Ca50. As reported in various case studies (e.g., Lin et al. [246]), 
calcium nitrate is still dissolved in pore liquids after gelation occurs during the sol-gel processing; thus, 
at this stage calcium nitrate is not incorporated into the sol-gel silicon-oxygen network. Consequently, 
the thermal treatment used to dry the gels resulted in the case of SG-Ca50 in the precipitation of crys-
talline calcium nitrate within the pores. This has not been observed for SG-Ca5 and SG-Ca12, most 
probably due to the significantly lower loading of calcium nitrate (Ca/Si = 0.05 and 0.12). 
The xerogels were converted thermally into silicon oxycarbide based materials via pyrolysis in inert gas 
atmosphere. In Figure 4-20 (a), the FTIR spectra indicate that the methyl groups were completely re-
moved after pyrolysis. Typical O-Si-O, Si-C and Si-O-Si vibration bands were identified for SiCa0, SiCa5 
and SiCa12; whereas in the case of SiCa50 the observed bands were mainly assigned to calcium silicate 
(pseudowollastonite) [199]. The crystallization of pseudowollastonite along with small amounts of wol-
lastonite in SiCa50 was confirmed by XRD analysis (see Figure 4-20 (b)). The crystallization of calcium 
silicates in SiCa50 was probably induced by the high amount of segregated calcium nitrate in the xero-
gel, which reacted with the silicon-oxygen network to form crystalline calcium silicate during the pyroly-
sis. 
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Figure 4-19. (a) FTIR spectra and (b) XRD diffractograms of xerogels SG-Ca0, SG-Ca5, SG-Ca12 and 
SG-Ca50. 
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Figure 4-20. (a) FTIR spectra and (b) XRD diffractograms of silicon oxycarbide samples SiCa0, SiCa5, 
SiCa12, SiCa50 (samples obtained from corresponding xerogel precursors via pyrolysis at 1100 °C in 
Ar atmosphere). 
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For the amorphous oxycarbides SiCa0, SiCa5 and SiCa12, FTIR spectroscopic data were used in order 
to assess their network architecture. As shown in Figure 4-21, four vibration bands have been fitted by 
Voigt functions: (i) band centered at 1190-1220 cm-1, corresponding to the longitudinal-optic (LO) Si-O-
Si asymmetric stretching [173, 247]; (ii) band centered at 1040-1090 cm-1, corresponding to the trans-
verse-optic (TO) Si-O-Si asymmetric stretching [173, 247]; (iii) band centered at 800-815 cm-1, corre-
sponding to the overlapping (denoted as OV) of symmetric Si-O-Si stretching, bending Si-O-Si vibration 
and Si-C vibration [173, 196, 222, 247]; (iv) band centered at 900-970 cm-1, corresponding to SiO4 tet-
rahedral units containing one non-bridging-oxygen (Q3) [198, 222]. As shown in Figure 4-21, the Q3 
component is found only in the fitted spectra of Ca-containing silicon oxycarbides, i.e., SiCa5 and 
SiCa12, clearly demonstrating the effect of Ca as network modifier in the silicon oxycarbide network. 
This is in agreement with the results from 29Si NMR analysis on Ca-containing silicon oxycarbides pre-
pared from Ca-acetylacetonate-modified polysilsesquioxane (see section 4.1.2). 
Since the band OV at ~800 cm-1 comprises both contributions from Si-O-Si and Si-C vibrations, the 
Q3/OV area ratio can be used to estimate the fraction of Q3 sites among the total Si species contained 
in the silicon oxycarbide network. As shown in Table 4-8, a significant increase of Q3/OV ratio from 
SiCa5 to SiCa12 is observed, corresponding to the increased Ca amount incorporated in the network of 
SiCa12 (as compared to that of SiCa5). Additionally, since Si-C vibration only appears in the OV band, 
the OV/(LO+TO) area ratio may be used to assess the fraction of Si species with Si-C bond in the silicon 
oxycarbide network. Interestingly, the OV/(LO+TO) ratio shows a decreasing tendency from SiCa0 to 
SiCa12, implying the decrease of network carbon content with increasing Ca2+ incorporation in amor-
phous network. This was also reported in previous studies related to the modification of silicon oxycar-
bide networks with earth alkaline network modifiers [66]. 
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Figure 4-21. Deconvolution of FTIR spectra (black lines) between 600 cm-1 and 1500 cm-1 for (a) SiCa0, 
(b) SiCa5 and (c) SiCa12 into LO ν(Si-O-Si), TO v(Si-O-Si), overlapping v(Si-O-Si)/v(Si-C) (OV) and Q3 
components (red lines). The sum of all fitted peaks yields the blue lines in spectra. 
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Fidalgo et al. [247] ascribed the LO-TO splitting in silicate glass networks to long-range coulomb inter-
actions and found out that a reduced LO-TO splitting may be related to the presence of high porosity, 
which disturbs the long-range coulomb interaction. As shown in Table 4-8, SiCa5 and SiCa12 show 
much lower LO-TO splitting than SiCa0, thus it is concluded that the prepared Ca-containing silicon 
oxycarbides possess significantly larger porosity than that of the ternary silicon oxycarbide SiCa0.The 
elemental compositions of the silicon oxycarbide samples prepared in this study can be estimated from 
their C and O contents and by assuming that Ca is present as calcium silicate in SiCa50 and as network 
modifier at the Q3 sites in SiCa5 and SiCa12 (see Table 4-9). All prepared silicon oxycarbide samples 
are shown to contain certain amount of segregated carbon, so-called “free carbon” [52]. Moreover, the 
decrease of the content of network carbon with increasing Ca2+ incorporation which was concluded 
based on the evaluation of the OV/(LO+TO) ratio in the FTIR spectra is clearly confirmed. The decrease 
of the carbon content in the oxycarbide network as well as its slight depolymerization due to the network 
modifier effect of Ca are considered to lead to decreased network connectivity in the series from SiCa0, 
to SiCa5 and to SiCa12. 
 
Table 4-8. Percentual peak area to the total fitting area and area ratios of fitted components and the 
calculated LO-TO splitting from LO and TO peak centers for SiCa0, SiCa5 and SiCa12. 
Sample 
LO 
Si-O-Si 
(%) 
TO 
Si-O-Si 
(%) 
OV 
Si-O-Si 
and Si-C 
(%) 
Q3 (%) Q3/OV OV/(LO+TO) 
LO-TO 
splitting 
(cm-1) 
SiCa0 26.8 53.1 20.1 - - 0.25 167.1 
SiCa5 33.3 41.6 14.6 10.5 0.7 0.20 127.4 
SiCa12 28.8 47.3 11.1 12.8 1.1 0.15 127.3 
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Table 4-9. Elemental contents, empirical formulae and estimated phase compositions of prepared silicon 
oxycarbide samples.  
Sample 
Si 
(wt.%) 
O 
(wt.%) 
C 
(wt.%) 
Ca 
(wt.%) 
Empirical Formu-
lae 
Estimated phase compo-
sitions 
SiCa0 47.92a 40.18 11.90 - Si1O1.47C0.58 Si1O1.47C0.27 + 0.31 C 
SiCa5 44.49a 41.65 10.68 3.18a Si1Ca0.05O1.64C0.56 Si1Ca0.05O1.64C0.21 + 0.35 C 
SiCa12 40.93a 42.64 9.41 7.02a Si1Ca0.12O1.82C0.54 Si1Ca0.12O1.82C0.15 + 0.39 C 
SiCa50 30.79a 41.10 6.11 22.00a Si1Ca0.50O2.34C0.46 
0.50 Si1O1.68C0.16 + 0.50 
CaSiO3 + 0.38 C 
a: Si and Ca contents are calculated from the difference to 100 wt.% and the Ca/Si molar ratios given in Table 3-2. 
 
Porosity evaluation 
The porosity of the xerogels as well as of the silicon oxycarbide samples was analyzed with N2 sorption. 
As shown in Figure 4-22, SG-Ca0 has an isotherm with mixed features of type I and type IV, while SG-
Ca5 has a type IV isotherm [207]. BJH pore size distribution of SG-Ca0 confirms the presence of high 
content of micropores (< 2 nm) and also a substantial amount of mesopores at 3.7 nm (see Figure 4-22 
(c)); whereas, SG-Ca5 contains a dominating part of mesopores around 25 nm (see Figure 4-22 (d)). 
Thus, SG-Ca0 shows significantly smaller pore size as compared to SG-Ca5, which corresponds to the 
significant shrinkage observed during gel drying for SG-Ca0 compared to SG-Ca5 (see Figure 4-23). 
Since capillary pressure induces pore shrinkage during drying [248], calcium nitrate precipitation from 
pore liquid (as mentioned before) during drying in SG-Ca5 may have probably stabilized pore walls, 
preserving the mesoporous gel structure in SG-Ca5 xerogel. On the other hand, although SG-Ca12 and 
SG-Ca50 are almost shrinkage-free (see Figure 4-23), their isotherms are mainly microporous type I 
(see Figure 4-24), indicating a pore-filling effect of calcium nitrate. Thus, calcium nitrate loading shows 
two effects on the porosity of xerogels: (i) at a low amount (Ca/Si = 0.05) calcium nitrate precipitation 
during gel drying stabilizes mesopores; (ii) at high amounts (Ca/Si = 0.12 and 0.50) precipitated calcium 
nitrate fills up pores, reducing the pore size, as illustrated in Figure 4-25. 
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Figure 4-22. N2 sorption isotherms of SG-Ca0 and SiCa0 in (a), SG-Ca5 and SiCa5 in (b) and the BJH 
desorption particle size distribution calculated for SG-Ca0 and SiCa0 in (c) and SG-Ca5 and SiCa5 in 
(d). 
 
   
Figure 4-23. Optical pictures of gels, aged gels and xerogels prepared in sol-gel process (see Figure 
3-2). 
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Interestingly, after pyrolysis at 1100 °C, the achieved SiCa5 has preserved its mesoporous structure 
(see Figure 4-22 (d)), while SiCa0 lost almost all of the micropores and mesopores observed in SG-Ca0 
(see Figure 4-22 (c)). The collapse of micropores was also observed on SiCa12 and SiCa50 (see Figure 
4-24). Since small pores contribute at the most to specific surface area [240], a significant decrease of 
BET specific surface area was observed for all samples after pyrolysis (see Table 4-10). The collapse 
and closure of micropores during the polymer-to-ceramic transformation of PDC ceramics have been 
investigated in various studies and were found to occur mainly at relatively high temperatures (> 600 
°C), where the gas evolution from thermal decomposition of residual organic groups ceased [240, 249, 
250]. In contrary, mesopores have been found to be more resistant against temperature [237] and show 
only a slight decrease of pore size after pyrolysis in the present study (see Figure 4-22 (d)). 
Furthermore, SEM surface morphology confirms the mesoporous structure of SiCa5 (see Figure 4-26 
(b)), while SiCa12 shows macroporosity (see Figure 4-26 (c)). The observed high porosity of SiCa5 and 
SiCa12 shows a good agreement with their low LO-TO splitting (see Table 4-8). Since SG-Ca12 is 
microporous, the macropores in SiCa12 must have been formed during the pyrolysis, namely via gas 
evolution during the removal of either residual organic groups or calcium nitrate, which decomposes at 
500-700 °C by outgassing NO2, O2,and N2 [251]. At a relatively high amount (Ca/Si = 0.12), precipitated 
calcium nitrate could have reached certain crystal/cluster size in SG-Ca12. Compared to nonporous 
SiCa0 (see Figure 4-26 (a)), the decomposition of such crystals/clusters would leave voids, which are 
able to grow to macropores with ongoing gas evolution. On the other hand, SiCa50 is mainly nonporous 
with surface morphology similarly to that of pseudowollastonite (see Figure 4-26 (d)) [252, 253]. 
Pseudowollastonite has good sinterability at 1100 °C [254, 255], and the sintering effect is considered 
to be responsible for the closure of pores left by calcium nitrate decomposition. Thus, calcium nitrate 
has different effects on the porosity of pyrolyzed silicon oxycarbide materials depending on its content: 
(i) at a low content (Ca/Si = 0.05), calcium nitrate decomposition does not influence the obtained mes-
oporosity noticeably; (ii) at a relatively high content (Ca/Si = 0.12), calcium nitrate decomposition in-
duces the formation of macropores; (iii) at a significantly high content (Ca/Si = 0.50), calcium nitrate 
reacts with the Si-O gel network to form crystalline calcium silicate, which sinters at 1100 °C and thus 
induces the elimination of pores, as illustrated in Figure 4-25. 
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Figure 4-24. N2 sorption isotherms of SG-Ca12 and SiCa12 in (a), SG-Ca50 and SiCa50 in (b) and the 
BJH desorption particle size distribution calculated for SG-Ca12 and SiCa12 in (c) and SG-Ca50 and 
SiCa50 in (d). 
 
Table 4-10. BET specific surface area (SSA) values calculated for xerogel samples and silicon oxycar-
bide samples from N2 sorption isotherms. 
BET Specific surface area 
SSA (m2/g) 
Ca/Si molar ratio 
= 0.00 
Ca/Si molar ratio 
= 0.05 
Ca/Si molar ratio 
= 0.12 
Ca/Si molar ratio 
= 0.50 
Xerogel 435.4 534.6 493.0 157.8 
Silicon oxycarbide 22.5 123.4 39.5 23.9 
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Figure 4-25. Schematic illustration of the porosity evolution from gels to xerogels and then to silicon 
oxycarbide materials and the porosity dependency on the designed Ca/Si molar ratio. 
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Figure 4-26. SEM surface morphology analysis of (a) SiCa0, (b) SiCa5, (c) SiCa12 and (d) SiCa50. 
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4.3.2. Biomineralization upon SBF exposure 
In order to verify and compare the bioactivity of Ca-containing silicon oxycarbides, their apatite forming 
ability upon exposure to SBF solution was evaluated. FTIR spectra of SiCa5-T and SiCa50-T, i.e., SiCa5 
and SiCa50 after 7 days of SBF test, show typical PO43- vibrations at 565 cm-1, 605 cm-1 and 1047 cm-1 
(see Figure 4-27 (a)), referring to the formation of hydroxyapatite-like calcium phosphate [147, 256, 
257]. In the case of SiCa12-T, only two small absorption notches at 565 cm-1, 605 cm-1 were observed, 
and the 1047 cm-1 vibration disappears under Si-O-Si vibration band. The precipitation of calcium phos-
phate on SiCa12-T is thus considered to be very limited. For SiCa0-T, no noticeable phosphate vibration 
is observable. XRD analysis (see Figure 4-27 (b)) confirms besides the formation of crystalline hydrox-
yapatite also the formation of calcite (CaCO3) on SiCa50-T. It has been reported, that the formation of 
calcite is induced by a high concentration of Ca2+ in SBF solution [258]. By taking into consideration the 
high Ca/Si molar ratio (0.50) in SiCa50-T, which leads to the formation of soluble calcium silicate 
(pseudowollastonite) phase [259], a high Ca2+ release is expected to have induced the calcite formation. 
Additionally, SiCa5-T and SiCa12-T are shown to be X-ray amorphous. The FTIR detectable calcium 
phosphate on their surfaces is thus either not crystallized or the amount of crystallized hydroxyapatite 
is still not significant to be detected by XRD. 
SEM analysis of SiCa5-T, SiCa12-T and SiCa50-T confirms the typical cauliflower-like morphology of 
hydroxyapatite on their surface (see Figure 4-28) [234, 235]. Interestingly, although no hydroxyapatite-
like precipitation was observed on SiCa0-T (see Figure 4-28 (a)), as also suggested by FTIR and XRD 
results, its surface shows a sort of coarsening compared to the surface before SBF soaking (see Figure 
4-26 (a)), indicating the occurrence of certain surface dissolution or leaching processes during SBF 
exposure. Indeed, Si release from ternary silicon oxycarbide takes place even though at a slow rate, 
according to our study of PMS derived ternary silicon oxycarbide (see section 4.1.3). The different shape 
and surface coverage of hydroxyapatite (HA) in Figure 4-28 shows clearly that SiCa50-T, with an almost 
complete HA surface covering, has the highest apatite forming ability among the investigated silicon 
oxycarbide samples. 
A comparison between SiCa5-T and SiCa12-T shows more active apatite formation on SiCa5-T than on 
SiCa12-T: hydroxyapatite grows on SiCa5-T to a size of several micrometers; whereas, hydroxyapatite 
clusters on SiCa12-T are much smaller (~ 0.5 um). Furthermore, the higher HA formation on SiCa5-T is 
also confirmed by FTIR results (see Figure 4-27 (a)). 
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Figure 4-27. (a) FTIR spectra and (b) XRD diffractograms of silicon oxycarbide samples after 7 days 
SBF test. 
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Figure 4-28. SEM surface morphology analysis of silicon oxycarbide samples after 7 days SBF test: (a) 
SiCa0-T, (b) SiCa5-T, (c) SiCa12-T and (d) SiCa50-T. The hydroxyapatite precipitation is marked in 
white circles for SiCa12-T. 
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4.3.3. Structure-property correlation 
Therefore, although SiCa12 with higher Ca content (Q3 fraction) and lower network carbon (see Table 
4-9) is expected to have lower network connectivity than SiCa5, the apatite forming ability, i.e., bioac-
tivity, is higher in SiCa5. It is well known, that low network connectivity leads to high dissolution of bio-
active glasses and thus high bioactivity [3]. However, the process to show bioactivity is also influenced 
by surface kinetics, as sol-gel derived bioactive glasses with high specific surface area could extend the 
range of SiO2 content for showing bioactivity [2, 212]. Thus, the observed discrepancy between network 
connectivity and apatite forming ability in the present study is probably influenced by the specific surface 
area or porosity in the same way. Mesoporosity in SiCa5 provides nearly three times higher specific 
surface area than that of macroporous SiCa12 (see Table 4-10). Correspondingly, SiCa5 shows higher 
apatite forming ability. Therefore, the introduction of mesoporosity to silicon oxycarbide proves to be an 
effective method to improve the apatite forming ability, i.e., bioactivity. Furthermore, mesoporosity is 
beneficial for obtaining additional functionalities, such as drug delivery ability or angiogenic effects. With 
limited Ca loading (Ca/Si = 0.05), SiCa5 is amorphous after 1100 °C pyrolysis. This high crystallization 
resistance is desirable if thermal processing of the material is anticipated [12, 150]. 
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5. Conclusion and Outlook 
The present work has investigated the structure-bioactivity correlation in SiOC based materials. On one 
hand, the SiOC network architecture and phase composition have been modulated upon incorporation 
of additional elements. On the other hand, sol-gel method has been applied to synthesize SiOC materi-
als with tunable specific surface area / porosity. The bioactivity of SiOC, assessed upon immersion in 
SBF solution, has been correlated to these structural features, i.e., network architecture, phase compo-
sition and porosity. 
The network architecture of SiOC can be modified in two ways: (i) network depolymerization by forming 
non-bridging-oxygens; (ii) tuning of the network carbon to network oxygen ratio. SiOC network can be 
depolymerized by incorporating alkaline earth metals (e.g., Ca), which act as network modifier. A slight 
depolymerization of SiOC network has a significant effect on improving the SiOC bioactivity upon SBF 
immersion. Furthermore, the network carbon to network oxygen ratio can be effectively decreased via 
incorporation of a small amount of boron, which acts as network former. Since the network carbon is 
tetravalent and the network oxygen is bivalent, a slight decrease of the network carbon to network oxy-
gen ratio leads to a significant reduction of SiOC network connectivity. However, a decrease of network 
connectivity related to the change of the network carbon to network oxygen ratio only has a slight effect 
on tuning SiOC bioactivity. 
Secondary crystalline silicate phases can be introduced to SiOC upon its modification with alkaline earth 
metals (e.g., Ca, Sr). Thus, a partition of alkaline earth metals into amorphous SiOC network and crys-
talline silicate phases has taken place, which is similar to the phase separation of silica/alkaline-earth-
metal-oxide melts at their immiscibility gap. Furthermore, the tendency to form crystalline silicate phases 
increases with increasing metal ion radius. Thus, while Ca modification induces negligible amount of 
wollastonite / pseudowollastonite (calcium silicate) phases, strontium silicate crystallization dominates 
upon Sr modification. The dissolution of secondary silicate phases in SBF solution modifies the local 
chemical environment to be beneficial for apatite formation. Thus, the bioactivity of SiOC materials is 
improved by the formation of secondary silicate phases. However, due to their rapid dissolution and 
consumption, the influence of secondary silicate phases on the bioactivity of prepared SiOC materials 
is considered to be a short-term effect. 
  
  91 
The porosity of SiOC can be tuned by Ca modification via sol-gel process. The introduction of a Ca 
modifier (e.g., calcium nitrate) modifies the porosity of the xerogel precursors. Additionally, the decom-
position of the Ca modifier and the formation of secondary calcium silicate phases influence the porosity 
of the resulting SiOC materials. Thus, at low content of Ca modifier, the xerogel porosity determinates 
the porosity of the resulting SiOC. In this way, mesoporous SiOC possessing high specific surface area 
can be achieved. With increasing Ca content, gas evolution upon the decomposition of Ca modifier plays 
an important role on increasing the pore size in the resulting SiOC and macroporous SiOC can be ob-
tained. At very high Ca content, calcium silicate crystallization dominates and its sintering at pyrolysis 
temperature closes pores and leads to nonporous SiOC based glass-ceramic. The porosity of SiOC 
materials is correlated to their varying specific surface area, which influences their bioactivity upon SBF 
immersion. Since the interaction between biomaterials and SBF solution occurs at the material surface, 
high specific surface area is beneficial for achieving high bioactivity. Correspondingly, the investigated 
mesoporous SiOC shows higher bioactivity than macroporous SiOC. 
In conclusion, tailor-made network architecture, phase composition and porosity in SiOC glasses and 
glass-ceramics have been shown to provide improved bioactivity. However, the present work has only 
assessed apatite forming ability of SiOC materials. Besides the influence on apatite forming ability, the 
depolymerization of SiOC network can tune Si release kinetics; a phase composition design with thera-
peutic ions will induce therapeutic ion release; the porosity of SiOC can be utilized for drug delivery or 
transport of growth factors. All these aspects should be assessed in a cellular environment in the future, 
in order to achieve a more comprehensive understanding of the structure-bioactivity correlation for SiOC 
materials. 
Thus, the future study should be focused on the investigation of cellular responses to released ions, 
particularly Si, Sr and B, from SiOC materials. A correlation of osteogenic and angiogenic effects to 
material structure would be crucial for designing clinically applicable bioactive SiOC materials. Further-
more, the high processability of SiOC precursors should be made use of to synthesize bioactive struc-
tures, such as 3D scaffolds or coatings. Particularly, wet-chemically based coating techniques, such as 
dip-coating or spin-coating, should be taken into consideration, since sol-gel method proves to be suit-
able for synthesizing Ca modified SiOC materials. 
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